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ABSTRACT
IDENTIFICATION AND CHARACTERIZATION OF DETERMINANTS OF HEAD
AND NECK TUMOR CELL INVASION
Yangguan Wu 
Eastern Virginia Medical School 
and Old Dominion University, 1999 
Director: Dr. Kenneth D. Somers
Head and neck squamous cell carcinoma (HNSCC) is a common malignant 
disease with poor prognosis. The majority o f patients die from local invasion or 
lymphatic metastasis. The mechanisin(s) underlining the invasiveness o f HNSCC are 
poorly understood. Utilizing a panel o f HNSCC cell lines previously established in our 
laboratory, we tested the application and relevance o f the three-step hypothesis o f tumor 
invasion to HNSCC and investigated the mechanism(s) pertaining to the regulation of 
each step in the invasive process. Data presented in this thesis demonstrated that tumor 
cell invasion in HNSCC is a complex process involving three repeated sequential steps: 
adhesion, proteolytic degradation o f the basement membrane and other extracellular 
matrixes (ECMs), and cell migration. These three steps are linked and interdependent. 
For example, cell adhesion to the ECM triggers a series o f  signal transduction pathways 
that involve calcium mobilization, focal adhesion kinase (FAK) activation, and 
downstream events leading to alteration o f cell function manifested by migration and 
matrix metalIoproteinase (MMP) production. Our working model extends the previous 
three-step hypothesis for tumor invasion by underscoring FAK as an integrator of 
multiple signaling pathways. Efforts to determine the role o f FAK in the integration and 
propagation o f signal transduction pathways should lead to a better understanding o f the
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molecular mechanisms for generating the invasive phenotype o f  HNSCCs which may, 
turn, lead to the discovery of new targets for therapy of invasive HNSCC.
R eproduced  with permission of the copyright owner. Further reproduction prohibited without permission.
This work is dedicated to my wife Ping Yin and my daughter 
Miaoting Wu. for their love, support and encouragement.
Reproduced  with permission of the copyright owner. Further reproduction prohibited without permission.
ACKNOWLEDGEMENTS
I would like to expression my sincere gratitude to the members o f my guidance 
committee: Dr. Timothy Bos. Dr. William J. Wasilenko, Dr. Ann E. Campbell, and Dr. 
Mark S. Elliott for their help and advice. My special thanks go to Dr. Kenneth D. Somers 
who served as a role model and mentor during my graduate training. His wit and insight 
in science helped my research to focus on important questions in cancer biology. His 
encouragement, guidance, editorial faculties, and kind words have made the demands o f a 
dissertation tolerable. No student could hope for a more reliant or gentle academic 
advisor than Dr. Somers. He has not only been an exemplary mentor, but also a valued 
friend.
I would like to extend my thanks to Ann Palad and Len Incognito as well as other 
staff in Department o f Microbiology and Molecular Cell Biology for help and technical 
assistance, and Dr. Peter F. Blackmore for assistance in measurement o f intracellular 
calcium.
I also thank Dr. Elise E. Kohn from the National Cancer Institute (NCI) for 
providing CAI; Dr. Willian G. Stetler-Stevenson from NCI and Dr. Timothy Bos for 
providing antibody to MMP-2 and TIMP-2; Dr. Wasilenko for providing monoclonal 
antibody to FAK and Dr. J. Thomas Parsons from University o f  Virginia for providing 
FAK antibody and FAK and FRNK cDNA.
R eproduced  with permission of the copyright owner. Further reproduction prohibited without permission.
Last, but not least, I would like to thank my parents, Chenxiang Wu and Wanxia 
Zhao, and my inlaws. Chaoli Yin and Benqiong Gong for their emotional support and 
help.






LIST OF TABLES........................................................................................................................  ix
LIST OF FIGURES........................................................................................................................ x
CHAPTER
I. INTRODUCTION.........................................................................................................  I
1.1 Overview o f  the Metastatic Process...................................................  1
1.2 The Invasive Phenotype: A Three-Step H ypothesis....................... 3
1.3 Cell Adhesion and Biological Consequences...................................  5
1.4 Proteolytic Degradation of the ECM..................................................  9
1.5 Signaling Pathways in Tumor Cell Invasion and M igration  16
1.6 Rationale and Focus o f the Present Study.........................................  23
II. MATERIALS AND M ETH O D S................................. ' ...........................................  27
2.1 Cell Lines and Cell Culture.................................................................. 27
2.2 Cell Adhesion A ssay............................................................................. 27
2.3 Chemoinvasion and Migration Assays............................................... 29
2.4 Collection o f  Conditioned M edium ...................................................  29
2.5 Zym ography...........................................................................................  30
2.6 Reverse Zymography............................................................................. 31
2.7 Western Blot Analysis o f MMP-2 and TIM P-2............................... 31
2.8 Assay for Effect o f ECM Proteins on Cell Migration
and MMP production..........................................................................  32
2.9 Assay o f  MMP-2 Antibody Treatment and Matrigel Invasion  33
2.10 Treatment o f  Cells with C A I.............................................................  34
2.11 Measurement o f Intracellular Free Calcium...................................  34
2.12 Immunoprecipitation and Immunoblotting Analysis o f  FA K   35
2.13 Generation o f  FAK and FRNK Eukaryotic Expression Vectors. 35
2.14 Transfection..........................................................................................  39
III. RESULTS.......................................................................................................................  40
3.1 Matrigel Invasion, Cell Migration, and Secretion o f MMP
Define the Invasive Phenotype o f HNSCC Cell L in es..................  40
3.2 Determine the Degree to Which MMP Production and 
Migration May Be Regulated by Cell-ECM Interactions................ 54
3.3 Determine the Role o f  MMPs in Invasion o f  H N SC C s................. 61
3.4 Calcium-Dependent Signaling and the Invasive Phenotype
o f H N SC C s............................................................................................  62
Reproduced  with permission of the copyright owner. Further reproduction prohibited without permission.
3.5 The Role o f Focal Adhesion Kinase in the Regulation o f MMP 
Production and Expression o f the Invasive Phenotype o f 
HNSCCs..................................................................................................  68
IV. DISCUSSION................................................................................................................
4.1 Involvement o f Three Sequential Steps: Cell Adhesion,
Proteolytic Degradation, and Cell Migration in Tumor
Invasion by Head and Neck Tumor C ells ..........................................  85
4.2 MMP-2 Production is Necessary for Matrigel Invasion.................  94
4.3 MMP Production and Cell Migration is Regulated by Integrin 
Mediated Cell-ECM Interaction...........................................................  96
4.4 Involvement o f Calcium Signaling in Regulation o f the
Invasive Phenotype o f HNSCCs...........................................................101
4.5 FAK Expression and Activation Is Important in Regulation
o f  the Invasive Phenotype o f HNSCCs............................................... 102








1. Summary o f HNSCC phenotypes........................................................................................  54
2. Invasive and FAK phenotype o f cell lines used for transfection.................................... 73
3. Summary o f transfection experim ents................................................................................  74
Reproduced  with permission of the copyright owner. Further reproduction prohibited without permission.
LIST OF FIGURES
Figure Page
1 -1. Multi-step cascade o f tumor cell metastasis...................................................................  2
1 -2. Three step hypothesis o f  invasion.....................................................................................  4
1 -3. Domains o f the matrix metalloproteinases.....................................................................  10
1 -4. Activation o f gelatinases on the cell surface..................................................................  13
1-5. Functional domains o f FAK and FRNK.......................................................................... 19
1-6. Integrin signaling pathways through FAK....................................................................... 21
1 -7. Schematic presentation o f  the invasive process o f HNSCC........................................  24
2-1. The strategy for construction o f sense FAK expression vector...................................  36
2-2. Construction o f the antisense FAK expression vector................................................... 37
2-3. Construction o f sense FRNK expression vector............................................................. 38
3-1. Matrigel invasion by HNSCC lines.................................................................................. 41
3-2. Cell migration o f  HNSCC lines........................................................................................  42
3-3. MMP production by head and neck cancer cell lines.................................................... 43
3-4. Quantitative densitometry o f MMP production by HNSCC cell lines......................  43
3-5. MMP production by HNSCC cell lines: comparison of zymography and
immunoblotting....................................................................................................................  45
3-6. TIMP-2 expression and secretion by HNSCC cell lines...............................................  47
3-7. Relationship between number o f cells and SRB staining.............................................  48
3-8. EVSCC14M cell adhesion to ECM proteins..................................................................  49
3-9. EVSCC17M cell adhesion to ECM proteins..................................................................  50
3-10. FTNSCC cell adhesion to ECM proteins.................................................................... 51
3-11. Inhibition o f EVSCC17M adhesion to ECM proteins by RGD tripeptide.............  52
3-12. Effect o f peptides GRGDSP and GRGESP on EVSCC17M adhesion to
fibronectin...........................................................................................................................  53
3-13. Effects o f  ECM protein on MMP production by HNSCC cell lines......................  55
3-14. Quantitative densitometry o f MMP-9 production following treatment with
fibronectin and laminin.................................................................................................... 56
3-15. Effect o f ECM protein on MMP production by HNSCC cell lines.......................... 57
3-16. Effect o f fibronectin on cell migration of HNSCC cell lin es ....................................  58
3-17. Effect o f laminin on cell migration o f HNSCC cell lines...........................................  58
3-18. Effect o f collagen type IV on cell migration of HNSCC cell lines........................... 59
3-19. Effect of R.GD or RGE peptide on EVSCC14M migration in response
to fibronectin....................................................................................................................... 60
3-20. Effect o f RGD or RGE peptide on EVSCC17M migration in response to
fibronectin............................................................................................................................ 61
3-21. Dose-dependent inhibition o f Matrigel invasion o f EVSCC14M by antibody
to M MP-2............................................................................................................................  62
3-22. Effect o f CAI on agonist-induced elevation o f [Ca2+] in EVSCC17M and
FaDu cells............................................................................................................................ 63
3-23. Dose-dependent effect o f  CAI on Matrigel invasion by EVSCC14M ...................  64
3-24. Effect o f CAI on invasive potential o f  HNSCC cell lines.......................................... 65
R eproduced  with permission of the copyright owner. Further reproduction prohibited without permission.
xi
Figure Page
3-25. Effect o f  CAI on migration o f  HNSCC ceil lines.........................................................  66
3-26. Effect o f  CAI on MMP production by HNSCC cells..................................................  67
3-27. Quantitative densitometry o f  MMP production by HNSCC cell lin es ..................... 67
3-28. Immunodetection o f p l2 5 FAK and phosphorylation o f p l2 5 FAK in
HNSCC cell lines................................................................................................................  69
3-29. Quantitative densitometry o f  FAK expression and basal levels o f
phosphorylation o f  FAK in HNSCC cell lines.............................................................  70
3-30. Restriction analysis o f  sense and antisense FAK expression vectors.......................  71
3-31. Restriction analysis o f  sense and antisense FRNK constructs................................... 72
3-32. Overexpression o f FRNK in EVSCC14M cells by transfection...............................  75
3-33. Effect o f FRNK expression on FAK phosphorylation in EVSCC14M
FRNK transfectants and controls..................................................................................... 76
3-34. Photomicrography o f  Matrigel invasion by EVSCC14M FRNK
transfectants and controls..................................................................................................  77
3-35. Matrigel invasion by EVSCC14M FRNK transfectants and contro ls......................  77
3-36. MMP production by EVSCC14M FRNK transfectants and controls.......................  78
3-37. Photomicrography o f  cell migration by EVSCC14M FRNK transfectants  79
3-38. Cell migration o f  EVSCC14M FRNK transfectants...................................................  79
3-39. Overexpression o f  FAK in EVSCC18 cells by transfection.......................................  80
3-40. Photomicrography o f  Matrigel invasion by EVSCC18 FAK transfectants  81
3-41. Matrigel invasion by EVSCC18 FAK transfectants..................................................... 82
3-42. MMP production by FAK transfectants.........................................................................  83
3-43. Cell migration o f  EVSCC18 FAK transfectants...........................................................  83




Head and neck squamous cell carcinoma is a common malignant disease. Nearly 
42.000 new cases o f  HNSCC and approximately 13,000 HNSCC deaths are estimated in 
the United States in 1998 (1). Globally. HNSCC accounts for 500.000 new cases annually 
and is the fifth most frequent cancer overall, comprising I o f  12 total malignancies. 
Despite improvements in current therapies, including surgery, radiation, and conventional 
chemotherapy, 5-year survival rates are low and have remained unchanged over the past 
20 years in whites but have decreased in African Americans (1-3). The major obstacle for 
the management o f  HNSCC is local-regional invasion and lymph node metastasis (3).
1.1 Overview o f the metastatic process
Metastasis is the spread o f tumor from a primary lesion to distant sites o f the body and 
represents the hallmark o f tumor malignancy. Successful metastasis formation involves 
multiple sequential steps (Fig. 1-1). At the cellular level, tumor cells initiate metastasis by 
detachment from the primary tumor and invasion o f the surrounding extracellular matrix 
(ECM), including the basement membrane and interstitial compartment, followed by 
intravasation o f the nourishing blood vessels or draining lymphatic vessels. Cells are 
then carried in the circulation until lodging in a distal capillary bed. The survivors o f the 
arrested cells then extravasate from the blood vessel, invade the surrounding tissues and 
The journal model for this thesis was Clinical Cancer Research.
R eproduced  with permission of the copyright owner. Further reproduction prohibited without permission.
begin to proliferate and form secondary tumors in the new organ environment (4). 
Angiogenesis. the recruitment o f new blood vessels, is required for primary' and 
metastatic tumors to grow to a clinically detectable size since the solid tumor never grows 
beyond 1 mm3 due to lack o f  nutrition. Tumor-induced angiogenesis not only allows for 
expansion o f the primary tumor, but also permits easy access to the vascular compartment 
as a result o f defects in the basement membrane of the newly formed vessels. Thus, 
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F ig l-I .  M ulti-step cascade o f tumor cell metastasis.
Many o f the steps in metastasis formation require specific interactions of tumor 
cells with the extracellular matrix and the nature and degree o f these matrix interactions 
will vary from step to step during the metastasis process (7,8). Escape of tumor cells from 
the primary tumor may require decreased adhesion to the tumor or stromal matrix. 
However, cell arrest in the target organ that results in tumor-specific patterns of
Reproduced  with permission of the copyright owner. Further reproduction prohibited without permission.
metastasis formation may be mediated by specific tumor-endothelial interactions and 
selective binding to specific matrix components. Only the metastatically competent cells, 
which exhibit different responses to various ECM and stromal cells, will successfully 
navigate each o f these interactions (7,8). Metastasis is known to be an inefficient process. 
Both clinical observations and experimental studies have demonstrated that large 
numbers o f tumor cells are shed into the blood circulation, but only a small fraction of the 
cells succeed in forming metastases (9). One o f the major contributors to this inefficiency 
is thought to be the traversal o f  the connective tissue barrier, an active process that is 
mediated by a specific cell-ECM interactions. Therefore, metastasis can be viewed as a 
process o f selection o f cells exhibiting invasive behavior characterized by their tendency 
to cross tissue boundaries and a subsequent growth advantage over normal tissue. To 
support this point, studies have demonstrated that individual metastases are likely to be 
clonal in origin (10).
1.2 The invasive phenotype: A three-step hypothesis
Tumor invasion is a complex and important process and marks the beginning o f 
metastasis. It has been proposed that tumor invasion involves three sequential steps: cell 
adhesion, proteolytic degradation o f the ECM, and cell migration through the ECM 
tunnel created by enzymatic proteolysis (Fig. 1-2) (11). The invasive process o f tumor 
cells shares many characteristics similar to normal physiological processes. Attachment, 
proteolysis, and migration are steps in trophoblast implantation, mammary gland 
involution, embryonic morphogenesis, and tissue remodeling. The difference between
Reproduced  with permission of the copyright owner. Further reproduction prohibited without permission.
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normal physiological processes and the pathological process o f tumor cell invasion lies in 
its regulation. Physiological processes are usually tightly regulated and self- limited.
Attachm ent T um or cell 
Endothelial cell






Fig. 1-2 Three step hypothesis o f  invasion.
whereas tumor invasion is unrestricted relative to the benefit o f  the host (12). Basement 
membrane is a special kind o f ECM upon which a variety o f cell types including 
keratinocytes in skin and endothelial cells in blood vessels rest. It serves as the tissue 
barrier at multiple key points in the metastatic cascade, namely, escape from the primary 
tumor in carcinoma, intravasation and extravasation during hematogenous dissemination, 
and perineural and muscular invasion. Thus, tumor invasion o f the basement membrane 
was thought to be the rate-limiting step in metastasis. Composed o f a dense meshwork of 
collagen type IV, laminin, and proteoglycans, the basement membrane does not normally 
contain pores that would allow passive tumor cell migration. Therefore, traversal o f  the 
basement membrane requires an active process defined by the invasive phenotype of 
tumor cells that is dominated by the ability o f tumor cells to attach to, degrade, and
R eproduced  with permission of the copyright owner. Further reproduction prohibited without permission.
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migrate through the ECM (reviewed in 13). In past decades, increasing interest was 
focused on deciphering the molecular mechanisms underlying the invasive process. The 
proposed three-step hypothesis has received extensive experimental support and has 
elucidated molecular events related to each step o f tumor invasion and subsequent 
metastasis formation (13). However, the step-wise process o f invasion has not been tested 
systematically in the context o f  HNSCCs. We propose to test the application and 
relevance of this model to HNSCC. To do this, cell adhesion to ECM proteins, 
matrix metalloproteinase (MMP) production, chemoinvasion, and cell migration will 
be assessed utilizing HNSCC cell lines developed in our laboratory. (Aim 1, Fig. 1- 
7.1)
1.3 Cell adhesion and biological consequences
Cell adhesion including cell-cell and cell-ECM adhesion represents the most 
direct form of tumor cell-host interaction. The capacity of tumor cells to adhere to other 
tumor cells, host cells, or components o f ECM could affect multiple steps of the 
metastatic cascade. Cell adhesion is mediated by a series o f cell adhesion receptors. 
Several families o f cell surface adhesion molecules have been identified, each with 
different functions and specificities (14,15) These molecules include the cadherins, the 
immunoglobulin cell adhesion molecule (Ig-CAM) superfamily, selectins, and integrins. 
Cadherins are calcium-dependent molecules that mediate homophilic cell-cell adhesion. 
Three subtypes (E-, N-, and P-cadherins) have been characterized. Loss o f the expression 
of cadherins results in the detachment o f tumor cells from the primary tumor site thus
Reproduced  with permission of the copyright owner. Further reproduction prohibited without permission.
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facilitating metastasis (16,17). The Ig-CAM superfamily, including N-CAM, I-CAM-1,I- 
CAM-2 V-CAM-1. CEA. and DDC, consists o f divalent cation-independent receptors 
that have several repeats o f  immunoglobulin-like folds characterized by P-pleated sheets 
held together by disulfide bonds. These molecules mediate both homotypic and 
heterotypic cell-cell adhesion (18). Selectins. acting through a terminal calcium- 
dependent lectin domain, are involved in heterotypic cell-cell adhesions between blood 
cells and endothelial cells. CD44, a homologue o f cartilage link protein, is a 
transmembrane GTP binding protein with intrinsic GTPase activity and functions as a cell 
surface receptor for hyaluronate. Under physiological conditions, most members o f Ig- 
CAM family, selectin. and CD44 function as regulators o f white blood cell trafficking 
and lymphocyte homing, whereas in the pathological process o f tumor invasion, they 
determine organ- specific metastasis (19).
Like cell-cell interactions, cell adhesion to the ECM is also accomplished by cell 
recognition of ECM proteins via cell surface receptors and represents the initial step in 
the process of tumor invasion (13). The most important cell surface receptors in cell- 
ECM interaction are integrins, heterodimers o f a  and P subunits that can pair to form 
more than 20 unique receptors (20). Different integrin receptors interact with different 
components of the ECM (eg., fibronectin, laminin, collagen type IV) by binding to 
integrin recognition sites consisting o f a short linear amino acid sequence, e.g. arginine- 
glycine-aspartic acid (RGD) (21). Integrin binding to the ECM and subsequent clustering 
leads to the formation o f  focal adhesions -  specialized sites o f contact -  where integrins 
link to intracellular cytoskeletal complexes and bundles o f  actin filaments. This complex
R eproduced  with permission of the copyright owner. Further reproduction prohibited without permission.
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of proteins piays an important role in modulating cell adhesion and regulating cell shape 
and mobility. Studies have shown that integrin-mediated cell-ECM interaction stimulates 
numerous complex biological processes including MMP production (22), cell migration 
(23-26). and changes in phosphorylation o f a number o f structural and signaling proteins.
a. Integrin-mediated cell ECM  interaction regulates cell migration
Several lines o f  evidence support the notion that integrin mediated cell-ECM 
interaction can regulate tumor cell migration. First, some ECM proteins including 
fibronectin, laminin, and type IV collagen were found to stimulate tumor cell locomotion 
(23-26). Fibronectin is a large multidomain glycoprotein in the connective tissue matrix. 
Each domain o f the fibronectin molecule is composed o f a set o f  type I, II, and III repeats, 
which together confer specific binding activities. The central cell binding domain 
contains the RGD sequence in repeat IIIio , which is essential for interaction with a 
number o f integrins including c d p i ,  avp3. allbp3 , and a v p 6  (27). Laminins are cross­
shaped heterotrimers composed o f a , P, and y chains, which exist as ten different variants 
and can assemble into eleven isoform combinations, lam inin-1 to laminin-11. The RGD 
containing sequence is located in the a  chain. Apart from RGD, 8 other recognition 
sequences were also identified in laminin. These sequences mediate the interaction with 
integrins including a 2 p i ,  a 3 p i ,  and a 6 p i (28). Type IV collagen is a polypeptide 
composed o f repeating hydroxyproline and hydroxylysine residues that, when 
polymerized, forms a sheet like network which is the fundamental structure o f most 
basement membranes. Type IV collagen preferentially binds to a i p i  integrin, however,
R eproduced  with permission of the copyright owner. Further reproduction prohibited without permission.
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a recognition sequence other than RGD may be required for interaction (29. 30). 
Fibronectin. laminin, and type IV collagen either in solution (chemotaxis) or coated on a 
solid membrane support (haptotaxis) induced tumor cell migration by a number o f tumor 
types (23-26). Secondly, expression o f certain integrins was associated with tumor cell 
motility. Studies have shown that expression o f  integrins a 2 p i. a 3 p i and a 6 p i 
correlated with invasive potential and cell motility o f  melanoma tumor cells. Moreover, 
anti-pi monoclonal antibody inhibits melanoma cell migration (31). Similarly, 
expression o f a 3 p i was found to be associated with cell migration o f malignant glioma 
(26). and expression o f a 6 p i is essential for migration o f breast carcinoma since 
knocking out a6p  I by a dominant deletion mutant reduced the motility o f  breast cancer 
cells (32). Third, disruption o f integrin mediated cell-ECM interaction inhibits tumor 
migration. The synthetic RGD containing peptide, which blocks integrin-Iigand 
interaction, successfully inhibits melanoma cell migration, and subsequently inhibits 
tumor invasion. However, relative high concentrations (1 mg/ml) are required to achieve 
these effects (33). Similarly, dysintegrin, a RGD containing peptide, obtained from snake 
venom, was found to have similar inhibitory activity (33).
b. Integrin mediated cell-ECM interaction regidates MMP production
Like cell migration, ECM proteins were also found to stimulate MMP production. 
Incubation o f ovary carcinoma cells in soluble fibronectin increased MMP-9 production 
by two-fold (34). Fibronectin was also found to stimulate MMP production by fibroblasts. 
Exposure o f osteogenic sarcoma cells to type I collagen induced elevated secretion of
R eproduced  with permission of the copyright owner. Further reproduction prohibited without permission.
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MMP-1 (35). Similar to ligand stimulation, cross-linking integrin receptors also increases 
MMP production. For example, antibody cross-linking o f integrin avp3 enhanced MMP- 
2 production by melanoma cells (36). Taken together, accumulating evidence supports the 
concept that integrin mediated cell-ECM interaction regulates MMP production.
Although substantial evidence supports the notion that cell migration and MMP 
secretion were regulated by integrin mediated cell-ECM interaction in other cell types, 
little is known about cell binding to ECM proteins and promotion o f gene expression and 
cell migration o f head and neck tumor cells. We hypothesize that MMP production 
and cell migration of HNSCC are regulated by cell-ECM interactions and propose 
to test this possibility by evaluating the alteration of MMP production and cell 
migration of HNSCC following exposure to ECM proteins. (Aim 2, Fig. 1-7.2).
1.4 Proteolvtic degradation of the ECM
Breachment o f the basement membrane and proteolytic degradation of the ECM 
is thought to be a rate-limiting step in tumor invasion (13, 37-39). Tumor cells employ 
proteases to accomplish this key step. Four families of proteases have been implicated in 
tumor invasion: (a) cysteine proteases (eg., cathepsin B,L), (b) aspartyl proteases
(cathepsin D, E), (c) serine proteases (eg., urokinase-type plasminogen activator), and (d) 
matrix metalloproteinases (MMPs). However, much of the attention has centered on the 
MMP family.
Reproduced  with permission of the copyright owner. Further reproduction prohibited without permission.
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a. MMP fam ily
MMPs are members o f a increasing family o f Zn2+-dependent endopeptidases 
characterized by secretion as a zymogen, activation achieved by proteolytic removal of 
the propeptide, function extracellularly at neutral pH, and inhibition by a specific class of 
biological inhibitors referred to as the tissue inhibitors o f metalloproteinases (TIMPs)
(40). Structurally, MMPs contain the following basic domains: a signal sequence; a
Furin cleavage site Transm em brane domain
(stromelysin-3<S^ M T-M M P) H inge region (M T-M M P)
/  /
d V d g C d
3<S^
E




M etal atom -binding domain
VAAHEXGHXXGXXH
Fig. 1-3 D om ains o f  the m atrix m etalloproteinases (rev iew ed  in 41). Each m em ber o f  the M M P 
family has a t least four dom ains (1). T he signal sequence directs the translation production to 
the endoplasm ic reticulum : (2) The propeptide dom ain  that is lost fo llow ing enzyme activation. 
(3) The catalytic dom ain that contains the conserved sequenceV A A H EX G H X X G X X H  in which 
the three histidine residues coordinate the active s ite  zinc (4) the carboxyl-term inal dom ain that 
has hom ology to hem opexin and vitronectin, is severely  truncated in m atrilysin. or contains a 
transm em brane dom ain in M T-M M P. In addition, th ere  is a  fifth dom ain that shows hom ology 
to the type II fibronectin repeats that bind gelatin and  is found only in gciatinases.
propeptide domain; a catalytic domain containing a zinc-binding site; a 54 amino acid 
long proline rich region homologous to the a2  chain o f type V collagen; and a hemopexin 
like carboxyl-terminal domain (Fig. 1-3). C-terminal domains are varied to confer 
substrate specificity. N-terminal domains are more conserved especially at the following
R eproduced  with permission of the copyright owner. Further reproduction prohibited without permission.
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regions: the amino-terminal profragment ‘activation locus’(PRCGxPD) and the catalytic 
domain o f the zinc binding site (HExGHxxHS/T) (40,41) . Three histidines in the 
conserved catalytic sequence complex with Zn atoms to form the active site, whereas a 
free cysteine in the propeptide m otif binds to the same Zn atom and maintains latency of 
MMPs. Activation is achieved by dissociation o f the propeptide from the catalytic 
domain. This dissociation represent a fundamental process for regulation of MMP 
activity. MMP activation can be achieved by auto-activation and by the action of other 
proteinases such as furin. urokinase, and plasmin (42). Activation o f  MMPs is subject to 
regulation by association with TIMPs, and once activated, may be inactivated by TIMPs 
and other plasma proteins such as a2-macroglobulin. Thus, the level o f  ECM degradation 
reflects a local balance o f MMP expression and activation versus the level o f  TIMPs. The 
four different TIMPs identified so far are expressed in different tissues and exhibit 
different specificities to complex and inhibit MMPs (41-43). Cell surface localization o f 
MMPs may achieve a highly regulated focus o f activity while widespread degradation 
may result from over-expression o f  unchecked secreted MMP. These features o f the 
MMP axis are significant in studying their contribution to both normal and pathological 
remodeling o f tissues (41-44).
To date, there are 20 members o f MMPs divided into six classes according to their 
substrate specificity and internal homologies: (a) the interstitial collagenases which 
degrade fibrillar collagens including type I. II, and III collagen; (b) the gelatinases which 
degrade denatured forms o f  collagen ( gelatin) and type IV collagen, the main form o f 
collagen in basement membrane; these MMPs also degrade type V, VII, IX and X
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collagens and fibronectin; (c) the stromelysins which have broad substrate specificity and 
degrade various components of the ECM including fibronectin. laminin and the core 
protein o f proteoglycans; (d) elastases which degrade elastin: (e) stromelysin-3 which 
targets alpha-1 -antitrypsin, and (f) membrane type (MT) MMPs. The last two groups are 
distinguished by the insertion of a furin cleavage site, RXKR, between the prodomain and 
catalytic domain. Presence o f this domain is important for the intracellular activation. 
Most MMPs are secreted while MT-MMPs have been shown to be membrane associated 
via a transmembrane domain at the carboxyl terminus o f the molecule (41,42).
b. Multilevel regulation o f  MMP-2 and MMP-9
MMP-2 and MMP-9 are two well characterized forms o f type IV collagenases 
(gelatinases) which share four common domains: the amino-terminal and zinc-binding 
domains shared by all members o f the MMP family, a collagen-binding fibronectin-like 
domain, and a carboxyl-hemopexin-like domain. The main structural difference between 
MMP-2 and MMP-9 is the presence o f a unique proline-rich domain homologous to the 
a2-chain o f type V collagen in the hinge region o f MMP-9 (13). MMP-2 is secreted as a 
72 kDa proenzyme which is activated by a recently identified membrane type-MMP 
(MT-MMP) to generate 62 kDa, 59kDa and 41-45 kDa active species(45,46). MMP-9 is 
secreted as a 92 kDa proenzyme and activated by plasmin, stromelysin, tissue kallikrein, 
and MMP-2 to generate a 82 kDa active species ( Fig. 1-4) (47). Activated forms of 
MMP-2 and MMP-9 are capable o f digesting mainly gelatin and type IV collagen. 
Therefore, MMP-2 and MMP-9 are also called 72 kDa type IV collagenase (or gelatinase
R eproduced  with permission of the copyright owner. Further reproduction prohibited without permission.
13
A) and 92 kDa type IV collagenase (or gelatinase B), respectively. Both latent and active 
forms of MMP-2 and MMP-9 can interact with TIMPs (48). TIMP-1, a 28 kDa 
glycoprotein initially isolated from rabbit bone and human fibroblasts, forms a stable 






Fig. I -4  Activation o f  gelatinases on the cell surface. TIM P, tissue inhibitor o f  
metalloproteinase; TBP TIM P-2 binding protein: uPA R. urokinase type plasminogen 
activator receptor: uPA urokinase type plasminogen activators: PAIs: plaminogen 
activator inhibitors; PLG. plasminogen; X indicats inhibition o f  the process.
TIMP-2 is a 21 kDa nonglycosylated protein that shows 66 percent overall homology to 
TIMP-1. TIMP-2 can form a complex with proMMP-2 and inhibits MMP-2 activation 
(51. 52). Both TIMP-1 and TIMP-2 can form a tight 1:1 stoichiometric noncovalent 
complex with MMP-9 and MMP-2, respectively (53). Formation o f TIMP-MMP 
complexes inhibits MMP activity and prevents autoproteolytic degradation o f MMPs. 
thus maintaining their integrity and substrate specificity (54).
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Recent studies demonstrated that inhibition o f MMP-2/MMP-9 is mediated by 
interaction between the N-terminal region o f MMP and the inhibitory TIMPs. 
Interestingly, the C-terminus o f TIMP-2. and only TIMP-2, was found to also interact 
with the C-terminus o f proMMP-2. However, this interaction does not inhibit MMP-2 
activity: instead, it is important for proMMP-2 activation. C-terminal TIM P-2 interacting 
with proMMP-2 and subsequent binding to a TIMP-2 binding protein o r MT-MMP. 
anchors the proMMP-2 to the cell surface in close proximity to M T-MM P which is 
activated intracellularly by a serine protease, furin. The intimate relationship between 
active MT-MMP and proMMP-2 significantly increases the efficiency for MMP-2 
activation (Fig. 1-4). Therefore, the effect o f  TIMP-2 on MMP-2 is paradoxical. At low 
concentrations, it stimulates MMP-2 activity, whereas at high concentrations, it inhibits 
MMP-2 activity. Pericellular activation o f  MMP-2 is a good example o f  spatial regulation
(41).
MMPs are also subject to transcriptional regulation. Transcriptional regulation o f  
MMP-2 and MMP-9 is different due to unique elements within each promoter. MMP-2. 
whose promoter lacks an AP-1 site, was found to be constitutively expressed in a wide 
range of tissues, whereas expression o f MMP-9 can be stimulated by a variety of growth 
factors, cytokines and ECM proteins in different cell types (43). Multilevel regulation o f  
MMP-2 and MMP-9 is biologically significant. Since MMP-2 and MMP-9 play 
important roles in both physiological (e.g angiogenesis) and pathological matrix 
remodeling (e.g tumor invasion), multilevel regulation of MMP-2/MMP-9 allows precise 
control o f MMP activity under physiological conditions. However, excess production and
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activation o f MMP or downregulated TIMP is thought to be a key feature o f the 
pathological process, notably tumor invasion (42).
c. MMP-2/MMP-9 and tumor invasion
The role o f MMP-2/MMP-9 in tumor invasion is well established. Secretion of 
MMP-2/MMP-9 is correlated with the invasive and metastatic phenotype o f several 
tumor types (55-57). Inhibition o f the expression or activity of gelatinases by the synthetic 
MMP inhibitor (batimastat), conserved MMP peptide sequences. (58-60) or by a 
ribozyme directed against MMP RNA (61) leads to reduced invasive and metastatic 
capacity. The role o f MMP-2/MMP-9 in tumor invasion and metastasis is further 
supported by recent clinical studies. Increased gelatinase A (MMP-2) activity was found 
in invasive tumor regions o f micro-dissected human colon cancer samples as compared 
to a matched number o f normal epithelial cells from the same patient (62). Consistent 
with this result, immunohistochemical studies have shown that most invasive colonic 
and gastric adenocarcinomas or desmoplastic stroma are immunoreactive for MMP-2. 
whereas benign proliferative disorders o f the breast and colon, and normal colorectal and 
gastric mucosa, show decreased or negative staining for this enzyme (63-66). Recent 
studies using a combination o f immunohistochemistry and zymography demonstrated 
that not only expression o f MMP-2/9 but, more importantly, activation o f MMP-2 was 
associated with tumor invasion and metastasis o f gastric, cervical and endometrial 
cancer (67.68). In contrast to MMPs, decreased TIMP expression has been asociated with 
invasive tumors (69,70). Exogenous TIMP-1 has been shown to inhibit in vitro tumor cell
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invasion o f human amniotic membranes and in vivo metastasis in animal models (71.72). 
Do\vn-regulation o f TIMP-1 expression by transfection o f antisense RNA into mouse 
3T3 cells enhanced their ability to invade human amniotic membranes and to form 
metastatic tumors in athymic mice (73). TIMP-2 has also been shown to successfully 
inhibit in vitro tumor invasion o f the ECM (74). Overexpression o f TIMP-2 in invasive 
and metastatic Ras-transformed rat embryo fibroblasts resulted in suppression o f the 
ability o f these cells to form lung colonies following intravenous injection into nude mice 
(75). An increased ratio o f MMP to TIMP has been detected in cervical cancer and 
stroma by in situ RT-PCR and found to correlate with poor prognosis (76).
Accumulating data demonstrated that MMP-2 and MMP-9 play an important role 
in the invasive process o f a variety o f tumors (55-76). However, the role o f MMP- 
2/MMP-9 in the invasive phenotype of HNSCCs has not been fully explored (67. 77). 
Preliminary studies from our laboratory demonstrated that HNSCC cell lines produce 
MMP-2 and/or MMP-9 and that secretion o f MMP-2 is associated with Matrigel 
invasion. The results link MMP-2 expression with a more aggressive tumor cell 
phenotype (78). To determine if MMP-2 is required for invasion of HNSCC, MMP- 
specific antibody was assessed for inhibition of Matrigel invasion and MMP activity. 
(Aim 3 Fig.l. 3).
1.5 Signaling pathways in tumor cell invasion and migration
As discussed above, cell-ECM interactions are mediated by specific classes o f
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integrins. Recent studies have shown that integrins not only regulate cell adhesion, but 
are also capable o f transducing signals across the plasma membrane (79,80) and 
regulating gene expression. To date, many components o f the integrin signaling pathway 
have been identified (81.82), but little is known about the precise molecular mechanisms 
by which integrin-mediated signal transduction mediates and/or regulates cell migration 
and MMP production.
a. Calcium and invasion
Calcium is one o f  the important intracellular second messengers. It participates in 
cell signaling by binding to specific cellular proteins including calmodulin and protein 
kinase C (PKC). Calmodulin is a calcium-regulated protein that is present in all cells. 
Although this protein does not have intrinsic catalytic activity, it does regulate other 
cellular enzymes such as adenylyl cyclase and Ca2+/calmodulin protein kinase. PKC is a 
serine/threonine protein kinase whose activation depends on binding o f calcium and 
diacvlglycerol (DAG). Activation of PKC leads to phosphorylation of specific cellular 
proteins in the target cell (83).
The concentration o f  cytosolic calcium in a resting cell is approximately 100 nM. 
In the endoplasmic reticulum (ER) and extracellular fluids, the calcium concentration is 
in the millimolar range. The calcium gradient is maintained by an ATP-dependent 
calcium pump. After cell stimulation, calcium levels in the cytosol transiently rise, 
enabling this cation to act on several calcium dependent proteins in the cytoplasm (84)
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Integrin stimulation was found to generate a rise in intracellular calcium. Cross- 
linking o f or adhesion via integrins has been shown to induce an increase in the 
intracellular calcium concentration in platelets with characteristics similar to inositol-
1.4.5-trisphosphate (IP3)-mediated calcium increases in other systems (85). Ligation o f 
av-p3 integrin on osteoclasts triggers mobilization o f calcium in the nucleus (86). whereas 
activation o f  integrins on endothelial cells results in elevation o f  intracellular calcium by 
an influx o f calcium through the plasma membrane (87). These findings indicate that 
calcium participates in integrin signaling. Accumulating evidence demonstrates that 
calcium homeostasis and calcium-regulated cellular events are important in the 
generation and maintenance o f  the malignant phenotype (88). We speculate that integrin 
mediated-calcium signaling may play a role in generating the invasive phenotype o f 
HNSCCs. Recently, work o f  others has shown that inhibition o f calcium influx by 
carboxyamidotriazole (CAI) attenuates focal adhesion kinase (FAK) phosphorylation and 
activation, indicating that mobilization o f intracellular calcium may be upstream o f FAK 
(89).
b. FAK and invasion:
Focal adhesion kinase was originally identified as one o f  several proteins that 
were highly phosphorylated in src-transformed cells (90). Subsequent cloning of this 
protein showed that it was a novel tyrosine kinase which localized to cellular focal 
adhesions (91). Focal adhesion kinase becomes phosphorylated upon adhesion o f 
Fibroblasts and transformed epithelial cells to the ECM. Temporally, FAK
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phosphorylation is coincident with cell spreading (92). and inhibitors o f cytoskeletal 
polymerization inhibit FAK phosphorylation. Additionally. FAK becomes 
phosphorylated on tyrosine in response to certain neuropeptides and growth factors, 
indicating that FAK may be involved in cross talk between integrin and growth factor 
signaling (93).
1. Structure o f  FAK
FAK is a member o f  a growing family o f structurally distinct cytoplasmic protein 
tyrosine kinases consisting o f  three functional domains (94). The catalytic domain, which 














Fig. 1-5 Functional dom ains o f  FAK and FRNK (review ed in 94).
noncatalytic domains that exhibit little sequence similarity to other proteins (Fig. 1-5).The 
FAK amino terminal domain is responsible for integrin binding, while the carboxyl-
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terminal domain mediates direct interaction with the adhesion-associated protein, 
paxillin. and targeting to the focal adhesion, defined as integrin-mediated sites o f contact 
between the cell and the ECM (94). Unlike many other nonreceptor tyrosine kinases. 
FAK lacks Src homology 2 or 3 (SH2 or SH3) domains, which mediate specific 
interactions with phosphotyrosine-containing sequences or proline-rich sequences, 
respectively (95). Instead. FAK contains consensus sequences that allow proteins with 
SH2 or SH3 domains to bind. Two proline-rich stretches, three tyrosine phosphorylation 
sites including a motif (YAEI) for the binding of Src SH2 domain, a motif (YMXM) for 
the binding o f the SH2 domain o f the p85 subunit o f phosphatidylinositol 3-kinase and a 
motif (YENV) for binding the Grb2 SH2 domain have been identified (96).
2. FAK substrates and signaling
FAK plays a central role in integrin-mediated signaling (Fig. 1-6). Integrins are 
receptors for extracellular matrix proteins. Presence o f SH2 and SH3 binding sites in 
FAK ensures activation of downstream events following integrin activation. However, the 
mechanism o f FAK activation is poorly understood. Studies have shown protein-protein 
interactions between the amino terminal domain of FAK and the cytoplasmic domain of 
the integrin (31 subunit, suggesting that the direct interaction may transduce the signal 
generated from integrin -ECM binding (97). Other data suggest that talin is an upsteam 
mediator o f FAK (98). Independent o f the mechanism, cell-matrix interaction results in 
autophosphorylation o f FAK at Tyr-397 which recruits Src through the SH2 domain (99). 
FAK/Src interaction releases autoinhibition of Src by displacement o f  the C-terminal
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regulatory tyrosine residue from the SH2 domain, resulting in Src enzymatic activity. 
This interaction is negatively regulated by C-terminal Src kinase (Csk) (100). Activated 
FAK/Src then phosphorylates substrates located in focal adhesions including paxillin. 
tensin. p l30cas, and cortactin (95) which regulate cytoskeleton assembly. Recently, 
phosphorylation o f FAK Tyr-397 was shown to be required for association with PI3-
ECM
Integrins
<( f r n k ) > ■ ' C a- '
FAK
CSOfr*' V PtdIns(4.5}P2Paxillin' ^
Cortactin









Fig. 1-6 Integrin signaling pathw ays through FAK. Binding o f  integrins to ECM 
leads to activation o f  FAK and its subsequent association with Src. The FAK/ Src 
complex then triggers several dow nstream  pathw ays, leading to altered gene 
expression or cytoskeletalchanges.
kinase (54). PI 3-kinase phosphorylates PtdIns(4,5)P2 to produce phosphatidylinositol
3.4.5-triphosphate [PrdIns(3,4.5)P3], which acts as a second messenger to activate PKC 
(101). Tyr-925 o f FAK is phosphorylated by Src and serves as the binding site for the 
Grb2/Sos complex. FAK:Grb2/Sos association relays the signal into the nucleus via the 
Ras-MAP kinase pathway (102). FAK is expressed in most cell lines and tissues 
examined to date (98). In some cells, the carboxyl-terminal domain o f FAK is expressed
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autonomously as a 41,000 Mr protein, termed FAK-related nonkinase (FRNK) (103). 
FRNK expression is regulated via a separate promoter within an intron o f the full-length 
protein [ J.T. Parsons, personal communication]. The function o f  FRNK is not clear. 
Since FRNK contains the focal adhesion targeting sequence, it is reasonable to speculate 
that FRNK may play a role in localization o f FAK to focal adhesion sites and in directing 
the binding of FAK to potential cellular substrates (91). Recently, FRNK was 
demonstrated to inhibit FAK phosphorylation and cell spreading following integrin 
activation, providing a novel mechanism for FAK regulation (104).
3. FAK and invasion
There are several indications that integrin signaling through FAK might be 
involved in tumor invasion and metastasis. Overexpression o f FAK has been detected in a 
number of invasive tumors (105,106), and phosphorylated FAK has been linked to the 
invasive phenotype and progression o f some tumors (107,108). Fibroblasts cultured from 
FAK knockout mice exhibited decreased motility but increased focal adhesion contacts, 
suggesting that FAK may play a role in focal adhesion turnover, which promotes 
migration (109). The regulation o f cell migration by FAK was further supported by the 
demonstration that FAK overexpression in CHO cells resulted in increased migration 
towards fibronectin, whereas mutation of the autophosphorylation site in FAK (Tyr-397) 
abolished the migration-stimulating effects (110). In addition to cell migration, the 
integrin-FAK signal transduction pathway is involved in the activation of MMP secretion. 
Down-regulation o f FAK expression by treatment with antisense oligonucleotides to FAK
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attenuated MMP-9 production by ovarian tumor cells (111). Whether FAK is involved 
in activation of MMP secretion and cell migration in HNSCCs has not been 
evaluated previously and is one aim of the present studies (Aim 5. Fig. 1-7.5).
1.6 Rationale and focus o f the present studv
Head and neck cancer is a common malignant disease with poor prognosis. The 
majority o f patients die o f local or regionally advanced disease. The mechanism(s) 
underlying the invasiveness o f head and neck squamous cell carcinoma (HNSCC) are 
poorly understood. Previous work from our laboratory has shown that inoculation o f 
HNSCC cells into the oral cavity o f nude mice demonstrated tumor growth and invasion 
at the orthotopic site, which mimicked the growth and invasive behavior o f human 
HNSCC (112). In contrast. HNSCC cells implanted subcutaneously in the scapular 
region o f nude mice formed localized tumors that were totally encapsulated by fibrous 
connective tissue (112). The results suggested that the tissue microenvironment and cell- 
ECM interactions were likely to be important determinants in regulation o f  the invasive 
phenotype o f HNSCC. How cell-matrix interactions and the microenvironment alter the 
invasive behavior o f HNSCC remain to be determined. Studies with other cell types have 
shown that cell-ECM interaction not only regulates the invasive process but also plays an 
important role in generating and transducing signals across the cell membrane (79). Many 
signal transduction pathways are activated by cell-ECM interaction (81). A few studies 
have suggested that Ca2+ dependent signaling (88) and activation o f focal adhesion 
kinase (82) are important in the regulation of cell motility and tumor invasion. We
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hypothesize that cell adhesion to ECM proteins triggers a series o f signal transduction 
pathways that involves Ca2+-dependent signaling, activation o f focal adhesion kinase and 
downstream events leading to altered cell function manifested by MMP production and 


































Fig. 1-7 Schem atic presentation o f  the invasive process o f  HNSCC. N um bers in 
circles indicate the specific aim s we propose in this study.
The overall aim o f  this thesis is to test the above hypothesis by characterizing 
determinants o f the invasive phenotype o f HNSCC and to investigate their role and 
involvement in regulation o f the invasive behavior of HNSCC. Our long-term goal is to 
identify intervention targets that might be exploited to control locoregional disease 
progression and improve prognosis.
The specific aims are to: 1. Characterize the invasive phenotype o f FINSCC. Cell lines 
derived from HNSCC were assessed for adhesion to ECM proteins, migration, Matrigel
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invasion and production of MMPs by zymography and immunoblotting. HNSCC cell 
lines were further assessed for expression of selective endogenous inhibitors o f MMPs. 
termed tissue inhibitors o f metalloproteinases (TIMPs), by immunoblotting and reverse 
zymography.
2. Determine the degree to which MMP production and migration are regulated by cell- 
ECM interaction. This was achieved by measuring MMP production by ECM protein- 
stimulated cells and assessing the effect o f  cell attachment to ECM on cell migration by 
chemotaxis using ECM proteins as chemoattractants. The specificity o f this integrin- 
mediated interaction was assessed with blocking peptides to adhesive recognition 
sequences.
3. Determine the role o f MMPs in invasion of HNSCC.. Antibody to MMPs was assessed 
for the ability to affect Matrigel invasion and MMP activity determined by zymography.
4. Determine the role o f  calcium signaling in the regulation o f MMP secretion and 
generation o f  the invasive phenotype o f HNSCCs.. The role o f calcium dependent 
signaling in generation o f the invasive phenotype o f HNSCC was assessed by testing the 
effect o f carboxyamido-triazole (CAI), a novel calcium influx inhibitor, on cell migration, 
MMP production, and Matrigel invasion.
5. Determine the role o f focal adhesion kinase (FAK) in the regulation o f MMP 
production and generation o f the invasive phenotype o f  HNSCCs. Specifically, a) FAK
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expression and its activation by phosphorylation in HNSCC cell lines was assessed by 
immunoprecipitation and immunoblotting and examined for association with the invasive 
phenotype determined by Matrigel invasion, migration and MMP production, b) Sense 
FAK or the catalytically inactive isoform, FAK-related non-kinase (FRNK). was 
expressed by transfection o f HNSCC cell lines to assess the consequences o f FAK or 
FRNK transfection on the invasive phenotype o f HNSCC cell lines. Sense FAK is 
expected to alter FAK expression, whereas sense FRNK expression is expected to inhibit 
FAK phosphorylation due to substrate competition. Manipulation of FAK expression 
and phosphorylation by transfection o f  head and neck tumor cells will assess directly the 
effects o f FAK on the invasive phenotype o f  HNSCCs.




2.1 Cell lines and cell culture
HNSCC cell lines derived from carcinoma o f the tongue (EVSCC14M. 
EVSCC17M, EVSCC19M) and larynx (EVSCC18) were established at Eastern Virginia 
Medical School (113, 114). Additional HNSCC cell lines, UMSCC10A and FaDu. were 
derived from SCC o f the larynx and hypopharynx, respectively (114). All HNSCC cell 
lines were cultured in EMEM supplemented with 10% fetal bovine serum (FBS) and non- 
essential amino acids. HaCaT, a spontaneously immortalized keratinocyte cell line (115) 
and RHEK-1, an SV40 T antigen immortalized human keratinocyte cell line (116) served 
as negative controls. HT1080. a human fibrosarcoma cell line, and A431 a 
wellcharacterized vulvar carcinoma cell line were used as positve controls for 
invasionand MMP production. NIH3T3 cells were used as a source o f conditioned 
medium for migration and chemoinvasion assays. HaCaT, RHEK-1, HT1080, A431 and 
NIH3T3 cells were grown in DMEM supplemented with 10% FBS. All cells were 
cultured at 37°C in 5% CCV95% air.
2.2 Cell adhesion assay
Adhesion assays were carried out in 96-well tissue culture plates ( Costar, 
Cambridge, MA) (117). The plates were coated overnight at 4°C with human plasma
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fibronectin. mouse laminin, and type IV collagen ( Gibco BRL. Gaithersburg, MD) at 
various concentrations. Plates were then rinsed three times in PBS and blocked by 
incubation in 0.1% heat inactivated bovine serum albumin (BSA) fraction V (Sigma. St. 
Louis. MO) for two hours at room temperature. The cells were harvested by trypsin- 
EDTA (Gibco BRL, Gaithersburg, MD) , washed once with growth medium containing 
10% FBS and remained in suspension for 1 hour at room temperature. The cells were 
then resuspended in serum-free medium containing 0.1% BSA and added to ECM 
protein- coated 96 well culture plates at a density o f 5x l04 cells/well. After 2 hours at 
37°C in a humidified atmosphere containing 5% CO2, non adherent cells were removed 
by rinsing twice in PBS, and the adherent cells were fixed with 10% trichloroacetic acid 
(TCA) at 4°C for 1 hour. The plates were then washed five times with tap water to 
remove TCA, air-dried, and stained for 30 minutes with 0.4% (wt/vol) sulforhodamine B 
(SRB) (Sigma, St. Louis. MO) dissoved in 1% acetic acid (118). At the end o f the 
staining period, SRB was removed and the plates were quickly rinsed four times with 1% 
acetic acid to remove unbound dye. The bound dye was extracted in 10 mM unbuffered 
Tris base [tris(hydroxymethyIaminomethane] (pH 10.5) for 20 minutes on a shaker. The 
optical density (OD) was read in a microtiter plate reader at 490 nm. To determine the 
effect o f RGD peptides on cell adhesion to ECM. The RGD peptide, GRGDSP or the 
control RGE peptide, GRGESP, ( Gibco BRL. Gaithersburg, MD) were added to the 
cell suspension at concentrations o f 0.5mM, ImM, 2mM or 4mM 30 min before the assay 
was initiated.
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2.3 Chemoinvasion and migration assays
Chemoinvasion and cell migration assays were performed in a 48-well modified 
Bovden chamber. Polycarbonate filters (pore size: 8pm, Nucleopore, Cabin John. MD) 
were first coated with type IV collagen (5pg/filter) (Gibco BRL. Life Technologies. 
Grand Island. New York ) and air dried. Matrigel (lmg/ml) in cold distilled water was 
layered onto each filter (500pg/filter). Filters were dried at room temperature and 
reconstituted with DMEM. Serum-free NIH 3T3 conditioned medium, obtained by 
incubation of cells for 24 hrs, was used as a source of chemoattractants unless otherwise 
noted. Cells were harvested by trypsinization and suspended in DMEM containing 0.1% 
BSA. The chamber was assembled using freshly prepared Matrigel-coated filters and 
NIH 3T3 conditioned medium was added to the lower chamber. A 56 pi sample o f cell 
suspension (2xl06/ml) was then placed in the upper compartment and incubated at 37°C 
in 5% CC>2/95% air for 5 hours. At the end o f the incubation, the cells on the upper 
surface of the filters were mechanically removed. Filters were fixed and stained with 
Diff-Quik (Baxter, McGaw Park, IL), and the number of invasive cells was counted using 
a microscope with an image analyzer. Cell migration assays in response to NIH 3T3 
conditioned medium were performed similarly in modified Boyden chambers using 
polycarbonate filters coated with 0.01 mg/ml gelatin which is permissive for cell 
attachment and migration.
2.4 Collection o f conditioned medium
T25 flasks seeded with 2x 106 cells were incubated at 37°C for 24 hrs, washed
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with ITS (insulin, transferrin, selenium; Sigma, St Louis, MO) medium and incubated in 
3 ml of ITS medium at 37°C for 24 hours. The conditioned medium (CM) was collected, 
centrifuged at 400xg for lOmin at 4°C to remove cells and cell debris, and stored at - 
70°C. For specific experiments, conditioned medium samples were concentrated 10-fold 
using an Amicon concentrator 10 (Millipore Corporation, Bedford, MA) which excluded 
molecules o f less than 10 kDa.
2.5 Zvmographv
Gelatin zymography was performed as described previously (119) using a mini­
gel apparatus (Bio-Rad, Richmond, CA). Briefly, aliquots o f CM (40pl) were loaded 
onto 10% acrylamide gels containing 1 mg/ml of gelatin. After electrophoresis, gels were 
washed twice for 30 min with 2.5% Triton X-100 and incubated in 50 mM Tris-HCl pH 
7.5. 150mM NaCl, 10 mM CaCh , 0.02% Brij-35 and 0.1% Triton X-100 overnight at 
37°C. The gels were place in 0.5% Coomassie Blue R250 dissolved in 40% ethanol and 
microwaved at full power for one minute. The gel was further stained in the same 
solution for 15 minutes and subsequently destained in three changes o f acetic acid- 
ethanol solution (10% acetic acid, 40% ethanol) at 30, 60, 60 minutes intervals. The gels 
were stored in 10% acetic acid solution at 4°C. The gelatinolytic activity was visualized 
as cleared regions o f the gel and quantitated by scanning densitometry o f individual 
lanes.
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2.5 Reverse Zvmographv
Reverse zymography was also performed on a mini-gel apparatus according to 
Festruccia et al (120). Aliquots ( 30 ul) o f lOx concentrated CM were loaded onto 10% 
SDS-polyacrylamide gels copolymerized with 1% (wt/vol) o f  gelatin and 25% o f 
EVSCC18 conditioned medium which served as a source o f  MMPs. Following 
electrophoresis o f samples. SDS was removed from the gel by exchange in 2.5% Triton 
X-100 solution which allows MMPs in the gel to renature. The gel was incubated 72 to 
96 hours in enzyme buffer (50 mM Tris, pH 7.5, 200 mM NaCl, 5 mM CaCF, 0.02% 
Brij-35), stained with 0.5% Coomassie Brilliant Blue R250, and destained in ethanol- 
acetic acid as described for zymography. Areas o f inhibition were visualized as blue 
bands on a clear background o f the reverse zymogram.
2.7 Western blot analysis o f MMP-2 and TIMP-2
Monolayer cell cultures (75-80% confluency) were rinsed with ice-cold PBS. and 
then solubilized in lysis buffer containing 150 mM NaCl, 50mM Tris, pH 7.5 1% Triton- 
X 100. 0.25% Na-deoxycholate, ImM PMSF, ImM N aV 04, 50 ug/ml leupeptin, 0.5% 
aprotinin for 20 minutes on ice. Cells were scraped from the culture vessels, transferred 
to 1.5 ml microcentrifuge tubes, and centrifuged for 15 min at 4°C at 105 x g. The 
supemants were aliquoted and stored at -80 °C. Protein concentration was measured 
using the BCA protein assay kit ( Pierce Chemical Co., Rockford, IL).
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Cell lysates (50ug) or concentrated conditioned medium were resolved by 10% 
SDS-polyacrylamide gel electrophoresis (SDS-PAGE). After electrophoresis, gels were 
equilibrated in transfer buffer consisting o f 25 mM Tris HCL, 190 mM glycine. 10% 
methanol. 0.02% SDS and then transferred to Immobilon P membranes ( Millipore. 
Bedford. MA) using a semi-dry electrophoretic transfer cell (Biorad, Richmond. CA). 
The transfer was carried out at room temperature for 40 minutes at 18 volts for MMP-2 
analysis, or 35 minutes at 15 volts for TIMP-2 analysis. Following transfer, the 
membrane was blocked for 1.5 hours in buffer containing 50 mM Tris (pH 7.5) 150 mM 
NaCl. 0.05% Tween 20 and 5 % non-fat dry milk. For analysis o f  conditioned medium, 
the membrane was incubated for 1.5 hours at room temperature with 0.5 ug/ml 
monoclonal antibody to MMP-2 or TIMP-2 (Oncogene Science, a gift from Dr. T. Bos). 
For analysis o f  cell lysates, membranes were incubated similarly with lpg/ml polyclonal 
antibody to MMP-2 and TIMP-2, obtained from Dr. Stetler- Stevenson, NCI. After three 
washes in 50mM Tris, 150 mM NaCl, 0. 01% Tween 20, the membranes were incubated 
in a horseradish peroxidase conjugated secondary antibody for one hour. Proteins were 
visualized by enhanced chemiluminescence (ECL) ( Amersham, Arlington, Heights, IL).
2.8 Assay for effect o f  ECM proteins on cell migration and MMP production
The migration assay was performed in modified Boyden chambers as described 
in section 2.3. The ECM proteins, fibronectin, laminin, or type IV collagen at 
concentrations o f 1, 10, 20,40, or 80 pg/ml were added individually to the lower chamber 
as chemoattractants, with BSA used as a negative control. Chambers were incubated at 
37°C and the assays were terminated at 5 hours. Cells on the upper surface were removed
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mechanically, whereas cells on the lower surface o f the membrane were stained and 
enumerated manually under 400 x magnification. The data are represented as the number 
o f migrated cells per high power field. To determine the specificity o f cell adhesion to 
ECM proteins. 0.5mM to 4 mM of RGD or RGE peptides were added to the cell 
suspension 2 hours before addition to upper chamber, and remained in the upper chamber 
during the migration assay.
To assess MMP production, cells (2 x 105 ) were plated into each well of a 24 
well tissue culture plate and allowed to attached overnight. Adherent cells were washed 
twice with serum-free ITS medium, and treated with ITS medium containing 10. 20. 40. 
or 80 pg/ml o f fibronectin, Iaminin, or type IV collagen. Serum-free ITS medium 
containing 80 pg/ml of BSA served as a negative control. Plates were incubated for 24 
hours at 37°C. Conditioned medium was collected and subjected to zymography as 
described in section 2.5.
2.9 Assay o f MMP-2 antibody treatment and Matrigel invasion
Matrigel invasion assay was performed as described in section 2.3. Different 
concentrations o f affinity purified anti MMP-2 rabbit polyclonal antibody ranging from
12.5 to 100 pg/ml were added to the upper chamber during the 5 hour assay. Normal 
rabbit antiserum (200 fig/ml) was added to the upper chamber as a control. The number 
o f invaded cells was counted in 5 high-powered fields at 400 X magnification and data 
presented as the number of invaded cells per high-power field.
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2.10 Treatment o f  cells with CAI
Carboxvamido-triazole (CAI) was generously provided by Dr. Elise Kohn. NCI. 
Bethesda. MD. T75 flasks were seeded with 106 cells in growth medium and cultured at 
37°C overnight to allow cell attachment. The next day. cells were washed with PBS and 
incubated in growth medium containing various concentrations o f  CAI (1 uM to 20 uM) 
for 24 hours. Cells were then harvested by trypsinization and chemoinvasion and 
migration assays performed as described in section 2.3. CAI was present throughout the 
procedure and in the upper and lower chamber during the five hour chemoinvasion and 
migration assay.
2.11 Measurement o f intracellular free calcium
Nearly confluent cultures o f  cells grown in T75 flasks were serum-starved for 4 hr and 
removed by brief trypsinization. Cells were washed and resuspended in phenol red-free 
Hanks' balanced salt solution (HBSS) supplemented with 0.1% BSA. fraction V 
( Sigma, St. Louis, MO). Cells were loaded with 4 pM o f  the calcium indicator dye Fura- 
AM (Molecular Probes, Eugene, OR) for 1 hr at 37°C as described previously (121, 122) 
Calcium mobilization was assesssed in Fura-2AM loaded cells using a SPEX ARCM 
spectrofluorimeter at 330 and 380 nm. Calcium levels in nanomolar values were 
calculated as described previously (122), using calibration in the presence o f CAI to 
compensate for any influence o f  CAI on fluorescence values.
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2.12 Immunoprecipitation and immunoblotting analysis o f  FAK
Immunoprecipitation was performed as described by Matsumoto et al (123). Briefly, 
cells (106 ) were cultured in growth medium containing 0.5% FBS for 18 hours. Serum 
starved cells were washed with PBS containing 0.1 mM N a3V 04, and lysed in 1 ml of 
modified RJPA lysis buffer consisting of 50 mM Tris HCL (pH 7.5), 4mM EDTA, 150 
mM NaCL. 10 mM sodium pyrophosphate. 10 mM NaF. 1 mM N aV 04, 0.1% sodium 
deoxycholate. 1 mM phenylmethysulfonyl fluoride. 10 ug/ml aprotinin. and 1% Nonidet 
P-40. Lysates were centrifuged at (105 x g) 4°C and supernatants were aliquoted and 
stored at -80°C. Protein concentration was determined as described in section 2.7. and 
cell lysates ( 800 pg protein) were precleared by incubation with protein A- agarose for 
1 hour at 4°C followed by centrifugation at room temperature at 5000 x g for 5 minutes. 
Supernatants were then transferred to fresh tubes and incubated at 4°C overnight with 8 
pg of monoclonal antibody to FAK (2A7, Upstate Biotechnology, Lake Placid. NY). 
Immunocomplexes were recovered using goat anti mouse IgG- agarose, separated by 
SDS-PAGE, and transferred to Immobilon-P. Membranes were probed with 
antiphosphotyrosine antibody (RC 20, 1 pg/ml) to assess FAK phosphorylation or 2A7 
antibody (1 pg/ml) to assess FAK expression, followed by incubation with peroxidase- 
conjugated goat anti-mouse IgG and the immunoreactive bands visualized by ECL.
2. 13 Generation o f  FAK and FRNK eukaryotic expression vectors
FAK and FRNK cDNA in Bluescript phagemids were kindly provided by J.T.
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Parsons (University o f  Virginia, Charlottesville, VA) and were cloned into the expression 
vector pSV.Sport 1 in the sense and antisense orientation. pSV. Sport 1 is commercially 
available eukaryotic expression vector containing the SV40 promoter and 
polyadenyaltion signal. It was chosen because of previously successful experiments in 
this laboratory using the vector to express the gene Ems-1/cortactin in fibroblasts (124). 
The strategy for construction o f  the sense FAK expression vector is shown in Fig. 2-1. 
Briefly. pSK. FAK was cut by Xho I , followed by treatment with Klenow DNA
|Sai I. 27 
Xho I. 33 
t.K pnI.48
Not I. 2920 
X'bal. 2828 
Bam H. 2940 
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Fig. 2-1  The strategy for construction of sense FAK expression vector. pSK.FAK is cut 
by Xho I, followed by treatm ent o f  Klenow DNA polymerase to generate 3 ’ blunt ends. The 
FAK inserts are obtained by restriction digestion with Not I which gives rise to  5 ’ sticky ends. 
Pvu I is added to cu t the vector backbone so that the FAK fragment is easier to separate from 
the vector. FAK fragm ents are ligated to  the multiple cloning site (M CS) o f  pSV. Sportl which 
has a blunt end near the poly A tail (generated by Mlu I digestion, followed by Klenow 
treatment) and a N ot I sticky end near the SV40 promoter. Not I sticky ends favor ligation in 
the normal orientation.
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polymerase to generate 3 ' blunt ends. The FAK insert was obtained by restriction 
digestion with Not I which gives rise to 5’ sticky ends. Pvu I was added to cut the 
Bluescript vector so that the FAK fragment was easier to separate from the vector 
backbone. FAK fragments were then ligated to the multiple cloning site (MCS) o f pSV. 
Sport 1 which has a blunt end near the poly A tail (generated by Mlu I digestion, follow 
by Klenow treatment) and a Not I sticky end near the SV40 promoter. Not I sticky ends 
favor ligation in the normal orientation. The ligation mix was transformed into competent 
E. coli DH5a by electroporation. Sense FAK expression clones were screened by 
restriction digestion with Dral. The strategy to generate the antisense FAK expression 
vector. pSV.aFAK, is shown in Fig. 2-2. Briefly, pSK.FAK was cut with Sal I and Xbal.
Pvu L I 706
Xba L 2928
Snu I. 2946
Sticky ’  =
( I 22 Kb - 1 67Kb) 3 3Kb
Xba I -P v u  I
£  A k  i  i i  ,
pSV SPORT! “ V m c s T  Sal 1
,a\ y  - •Not I 
Poly A \ \ b a |
Xba I




Fig.2-2 Construction o f  the antisense FAK expression vector. pSK .FA K  is cu t with 
Sal I and Xbal. Full length FAK w ith a  3 ’ Sail sticky end and a 5 ' Xba I end is ligated 
to MCS o f  pSV. Sport 1. Since the Sal I site is near the promoter, w hereas the Xbal 
site is near poly A tail, the ligation favors insertion in the the reverse orientation.
Full length FAK with a 3’ Sal I sticky end and a 5’ Xba I end was ligated to the MCS o f 
pSV.Sportl. Since the Sal I site is near the promoter, whereas the Xba I site is near the
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poly A tail, the ligation favors insertion in the reverse orientation. The antisense FAK 
clone was screened by digestion with Dra I (Fig. 2-2).
Sense and antisense FRNK expression vectors were cloned by EcoR I digestion 
o f pSK FRNK followed by ligation to the EcoR I site in the MCS o f  pSV.Sportl. pSV. 
Sport 1 was treated with alkaline phosphatase before ligation to prevent self-religation and 
to improve efficiency. EcoR I released FRNK can be ligated to the EcoR I site in the 
MCS o f pSV.Sportl in either orientation. The FRNK clones were screened by Hind III
E coR  I
H ind  III
pSK  FR N K  
4142
E coR  I
E coR  I
I I K b
y V 4°  ,  E coR  I 
p S V S P O R T ^  / x b a





H ind IIIH in d  III
pSV  aF R N K  
4 3 K b '
pSV  F R N K  
4 3 K b
L E coR  I 
Polv A
1 E coR  I 
P o ly  A
Fig. 2-3  C onstruction o f  sense FRNK  expression vector. Sense FR N K  expression vector 
is cloned by EcoR I d igestion  o f  pSK .FR N K  followed by ligation to  the EcoR  I site in 
MCS o f  pS V .S portl. pS V .S portl is treated with alkaline phosphatase before ligation to 
prevent self-ligation and to im prove efficiency. EcoR I released F R N K  can be ligated 
to EcoRl site in M CS o f  pS V .S portl in either orientation.
digestion (Fig. 2-3).
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2.14 Transfection
Cell transfection was performed with Fugene 6 reagents ((Boehringer Mannheim. 
Indianapolis. rN) according to the manufacturer's instructions. Briefly. 5 x 104 cells were 
plated in six well tissue culture plates and grown overnight in growth medium. On the 
second day. the medium was replaced with 3 ml o f  fresh medium and transfection was 
accomplished by dropwise addition o f  the transfection mixture onto the cells. Briefly. 
10-15 pg of FAK or FRNK plasmid DNA and 0.5-1 fig o f pSV2neo plasmid DNA or 
pSV2neo DNA alone was transfected, using Fugene 6. into recipient cells. Stable 
transfectants were selected by growing cells in 400 pg/ml o f G418 (Gibco BRL. Grand 
Island. NY). Drug-resistant colonies were picked 15-20 days after transfection and clones 
expanded in G418 containing medium for subsequent analysis. Cells transfected with 
pSV2neo alone were selected similarly, single cell clones were expanded and used as 
controls. Candidate clones were screened to verify FAK or FRNK expression by 
immunoblotting with BC3 polyclonal antibody which recognizes epitopes in the C- 
terminus of FAK. Selected clones were assessed for the invasive phenotype including 
Matrigel invasion. MMP production and cell migration.




3.11 Matrieel invasion, cell migration, and secretion o f MMP define the invasive 
phenotype o f HNSCC cell lines
a. Matrigel invasion and cell migration.
The mechanisms underlying the invasiveness o f head and neck squamous cell 
carcinoma are poorly understood (3). Previous studies from our laboratory suggested that 
cel 1-matrix interactions play an important role in regulation o f the invasive phenotype of 
HNSCCs (4). To further dissect the molecular mechanisms that regulate the invasiveness 
o f HNSCC. we have developed a series o f HNSCC cell lines. Our initial goal was to 
characterize the invasive phenotype o f HNSCCs. To do that, we measured Matrigel 
invasion o f HNSCC cell lines by a chemoinvasion assay which measures the capacity o f 
cells to penetrate an in vitro reconstituted basement membrane of Matrigel in response to 
chemoattractants.
Six HNSCC cell lines were evaluated. HNSCC cell lines derived from carcinoma 
of tongue (EVSCC14M. EVSCC17M, EVSCC19M) and larynx (EVSCC18) were 
established at Eastern Virginia Medical School. Additional HNSCC cell lines, 
UMSCC10A and FaDu, were derived from SCC of the larynx and hypopharynx, 
respectively. HT1080, a human fibrosarcoma cell line, and A431, a well-characterized
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vulvar carcinoma cell line, served as positive controls for invasion. RHEK-1. an SV40
T-antigen immortalized human keratinocyte cell line, and HaCaT, a
spontaneousimmortalized human keratinocyte cell line, served as negative controls. 
HT1080 and A431 were highly invasive in the chemoinvasion assay, whereas. HaCaT
and RHEK-1 cells were weakly and moderately invasive, respectively (Fig. 3.1). 
HNSCC cell lines exhibited a range o f  invasive potential and were classified as highly 
invasive (EVSCC14 M. EVSCC17M) or weakly invasive (EVSCC18. EVSCC19M. 
UMSCC10A. FaDu) (Fig.3-1).
Fig.3-1 Matrigel invasion by HNSCC lines. Invasion assays were conducted 
with Matrigel-coated 8 pM- pore size polycarbonate membranes in a modified 
Boyden chamber and was measured after 5 hours of exposure to 3T3 
conditioned medium. Cells on the underside of the membrane were stained 
and counted by a image analyzer. Results are means (Bars, SE) of two 
independent experiments, with a total of six replicates.
To assess if cell migration contributes to the invasive phenotype o f  HNSCCs. we 
examined cell motility o f HNSCCs by a chemotaxis assay. Similar to Matrigel invasion, 
HNSCCs also exhibited different motilities. EVSCC14M and EVSCC17M were highly
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Fig.3-2 Cell migration of HNSCC lines. Migration assay were performed 
as described for the chemoinvasion assay, except that polycarbonate 
membranes were coated with diluted gelatin. The results are the means 
(bars.SE) of two independent experiments.
b. MMP secretion.
Because MMPs play an important role in cancer cell invasion and MMP 
expression is correlated with the metastatic capacity o f various tumors (reviewed in 19), 
we screened HNSCC cell lines for MMP secretion by gelatin zymography. and 
quantitated levels o f gelatinolytic activity by densitometry as described previously (78). 
All HNSCC cell lines secreted MMP-2 and/or MMP-9 (Fig3-3). EVSCC19M and 
UMSCC10A cells secreted increased MMP-9 relative to MMP-2, whereas EVSCC14M 
and EVSCC18 cells secreted MMP-2 at higher levels than MMP-9; FaDu cells secreted 
minimal levels o f  both MMP-2 and MMP-9 (Fig.3-3 and Fig.3-4).




Fig.3-3 MMP production by head and neck cancer cell lines. Cells were 
incubated in serum free medium for 24 hrs and the conditioned medium (CM) 
collected. The MMP activity in CM was assessed by gelatin zymography. 
Shown is a representative zymogram of CM from HNSCC cell lines. Arrows 
indicate the position of 92 kD MMP-9 and 72kD MMP-2.




Fig.3-4 Quantitative densitometry of MMP production by HNSCC 
cell lines. MMP activity of CM was assessed by gelatin zymography 
and quantitated by densitometric scanning of individual lanes and 
expressed as net intensity.
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association between MMP-2 secretion and invasion (See Summary of HNSCC 
Phenotypes Table 1. p.54). The correlation was seen most dramatically with highly 
invasive EVSCC14M and control A431 cell lines which secreted abundant amounts o f 
MMP-2 but barely detectable MMP-9. Conversely, weakly invasive EVSCC19M and 
UMSCC10A cells secreted enhanced levels o f MMP-9 but reduced levels o f MMP-2 
suggesting that a threshold level o f  MMP-2 activity may be required for invasion in a 5 
hour in vitro invasion assay. EVSCC18 cells were a notable exception to the association 
between MMP-2 secretion and invasion. However, EVSCC18 cells exhibited limited 
migration potential despite enhanced MMP-2 secretion (see Fig. 3-4) emphasizing the 
interdependence o f MMP secretion and cell migration in the fully invasive phenotype. 
Finally, the weakly invasive and migratory phenotype of FaDu cells which secrete barely 
detectable MMPs support the notion that MMPs play an important role in the invasive 
potential o f  HNSCCs.
To confirm the results o f MMP production detected by zymography. cell lysates 
and conditioned media (CM) from the HNSCC lines were analyzed for MMP expression 
by immunoblotting with MMP-specific antibodies. Since zymography demonstrated that 
MMP-2 was associated with the invasive phenotype o f HNSCCs, we focused on MMP-2 
expression in subsequent experiments. In preliminary experiments, we detected minimal 
MMP-2 by immunobloting o f non-concentrated conditioned media from MMP-2 over­
expressors, HT1080 and EVSCC14M. Therefore, we used 10-fold concentrated 
conditioned media for further analyses. We found that MMP levels in the conditioned 
media detected by immunoblotting (Fig. 3-5, middle panel) correlated in part, but not
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exactly, with MMP activity as assessed by zymography (Fig.3-5, upper panel). For 
example. EVSCC14M. EVSCC17M. EVSCC18, and A431 which exhibited the higher 
levels o f MMP-2 activity by zymography, also showed elevated levels o f  M MP-2 
production detected by western blot analysis. Similarly, EVSCC19M. UMSCC10A and 
FaDu. which had lower levels o f  MMP-2 detected by zymography. consistently exhibited 
reduced MMP-2 protein detected by immunoblotting. In western blot analysis, we also 
detected lower molecular weight bands (see lane 1 and lane 2. Fig. 3-5) which may
92 kO. MMP-9 - •  
72 kD, MMP-2 - * Zymography
72 kD. MMP-2 — Western Blot 
CM 10X
72 kD, MMP-2 —
£  £  &  ,p° &
&  J ?  £  #
Western Blot 
cell lysates
Fig. 3-5 MMP production by HNSCC cell lines: comparison of zymography 
and immunoblotting. Each experiment has been repeated 2-3 times. Upper 
panel shows a representative zymogram of CM from HNSCC cell lines.
The middle panel is a representative anti MMP-2 western blot of 10x CM 
from HNSCC cell lines. The lower panel represents the anti-MMP-2 western 
blot analysis of cell lysates (50 pg protein/lane) of HNSCC cell lines. Arrows 
indicate the position of 92 kD MMP-9 and 72 kD MMP-2.
represent activated forms o f MMP-2. We also analyzed MMP-2 expression in cell 
lysates of HNSCC cells by western blotting. MMP-2 expression in cell lysates was 
correlated generally with MMP-2 secretion in most cell lines except FaDu and A431. 
FaDu exhibited a high level o f  MMP-2 protein in cell lysates but barely detectable
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enzyme activity in CM. In contrast, A431, exhibited minimal MMP-2 protein in ceil 
lysates but showed high levels o f MMP-2 enzyme activity in CM (compare Fig.3-5, 
middle and lower panels). Data presented in Fig 3-5 shows minimal MMP-2 detected by 
western blotting in CM o f HT1080 cells compared to a strong bound o f enzymatic 
activity detected by gelatin zymography. In repeated experiments. MMP-2 levels detected 
by western blot in CM o f  HT1080 were comparable to levels detected by zymography.
b. TIMP-2 secretion
We have characterized MMP secretion by HNSCC cell lines and demonstrated 
that MMP-2 is associated with cells o f high invasive potential. Because TIMP-2 forms a 
specific 1:1 complex with MMP-2 (62), we assessed TIMP-2 expression and secretion by 
HNSCC cell lines.
To assess TIMP-2 secretion, concentrated conditioned media collected from 
HNSCC cell lines, was subjected to reverse zymography using EVSCC18 conditioned
medium as the source o f  MMP-2. Conditioned medium from HT-1080 fibrosarcoma
cells, known to secrete TIMP-1 and TIMP-2, was used as a positive control.
As expected, two undigested bands (the 27 kD, TIMP-1 and 21 kD, TIMP-2) 
were detected in HT1080 conditioned media in original gel, but are barely visible in the 
photographic reproduction o f the gel ( Fig. 3-6, upper panel, lane 1). CM from HNSCC 
cell lines exhibited different levels o f  TIMP-2 activity. EVSCC14M and EVSCC18 
showed detectable levels o f  TIMP-2 activity, whereas the other cell lines showed
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minimal to no TIMP-2 activity (Fig.3-6, upper panel). HNSCC cell lines also exhibited 
different levels o f  TIMP-1 activity detected as a 27 kD band by reverse zymography. In 
addition to TIMP-l and TIMP-2, CM from EVSCC14M and EVSCC18 cells displayed a 






Fig. 3-6 TIMP-2 expression and secretion by HNSCC cell lines. TIMP-2 
secretion in CM was analyzed by reverse zymography (upper panel) and 
confirmed by immunoblotting (middle panel) as described in Materials and 
methods). TIMp-2 expression in HNSCC cell lines was analyzed by immuno­
blotting using cell lysates from HNSCC cell lines. Each is experiment has been 
repaeted 2-3 times. Shown is a representative data from each experient.
To confirm TIMP-2 detection by reverse zymography, concentrated conditioned 
media were analyzed by immunoblotting using a monoclonal antibody to TIMP-2. Levels 
of TIMP-2 detected by immunoblotting correlated closely with levels detected by reverse 
zymography (Fig.3-6. middle panel) with the exception o f HT1080 (lane l) in this 
experiment as noted above.
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immunoblotting analysis o f  cell lysates. TIMP-2 expression was correlated with TIMP-2 
secretion in 4 out o f 6 cell lines. TIMP-2 detected in cell lysates o f FaDu and A431 was 
not detected by immunoblotting or reverse zymography in CM (compare Fig.3-6. lower 
panel with middle and upper panels).
d. Cellular adhesion o f HNSCC cells to ECM proteins.
Cell adhesion to the ECM. mediated by integrins, is a critical step in the process 
o f invasion. To further characterize the invasive phenotype o f HNSCC cells, we assessed 
the ability o f cells to adhere to ECM proteins by an in vitro cell adhesion assay as 
described in the Materials and Methods section. In this assay, cell adhesion is measured 
by the protein-binding dye, SRB. In a preliminary experiment, we demonstrated a linear 
relationship between the number o f cells and optical density (490 nm) o f  SRB staining 
(Fig.3-7) with a regression coefficient o f  0.994 (p<0.001). The limit o f  the SRB assay is
0 .6-1
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Fig. 3-7 Relationship between number of cells and SRB staining. Cells were 
plated at densities from 2500 to 5x104 cells per well in a 96 well tissue culture 
plate, allowed to attach overnight and the SRB assay performed as described 
in Materials and Methods. Shown is a regression analysis of the data. The 
regression coefficient is 0.994. P<0.001.
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between 5000 and 5 xlO4 cells/well (Fig. 3-7). Therefore, the SRB assay was used in 
subsequent experiments to enumerate the number o f adherent cells in adhesion assays.
To determine the optimal dose o f  ECM  proteins for adhesion assays, EVSCC14M 
and EVSCC17M cells were tested for their ability to attach to 96 well plates coated 
overnight with 0.1 pg -  100 pg/ml o f fibronectin. laminin. or type IV collagen. Plates 
coated with 100 pg/ml o f BSA were used as negative controls. EVSCC14M cell 
adhesion was potentiated by laminin or fibronectin in a dose dependent manner, whereas 
adhesion to type IV collagen was not dose-dependent (Fig. 3-8). Fibronectin or laminin 
(100 pg/ml each) increased EVSCC14M cell attachment approximately 20-fold (Fig. 3- 





Collagen IV Laminin Fibronectin
Fig. 3-8 EVSCC14M cell adhesion to ECM proteins. Cell adhesion assay 
was performed as described in Materials and Methods. The results are the 
means (bars, SE) of two independent experiments, with a total of six 
replicates.Cell adhesion to ECM proteins was significantly increased as 
compared to BSA (P<0.001).
dependent adhesion o f EVSCC17M cells (Fig.3-9). We noted that EVSCC17M cells 
exhibited a higher background attachment to wells coated with BSA alone than
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EVSCC14M cells. Nevertheless, fibronectin or laminin (100 pg/ml each) increased 
EVSCC17M cell attachment 5 fold and 3 fold, respectively (Fig. 3-9).
mmm b s a
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■ ■ ■  10 iig/ml
Laminin Fibronectin Collagen IV
Fig. 3-9 EVSCC17M cell adhesion to ECM proteins. Cell adhesion assay 
was performed as described in Materials and Methods. The results are the 
means (bars, SE) of two independent experiments, with a total of six 
replicates.Cell adhesion to ECM proteins was significantly increased as 
compared to BSA (P<0.001).
Since EVSCC14M and EVSCC17M cell attachment was highest at 100 pg/ml 
ECM protein doses, we assessed the ability o f the other HNSCC cell lines to adhere to 
plates coated with 100 pg/ml o f collagen type IV. fibronectin, laminin, or Matrigel (a 
combination o f type IV collagen, laminin, and fibronectin). HNSCC cell lines adhered 
poorly to BSA except EVSCC17M (data not shown). HNSCC cells exhibited a 
differential ability to adhere to ECM proteins. EVSCC14M, 17M 19M, and UMSCC10A 
were significantly more adhesive than weakly adhesive EVSCC18 and FaDu cells (Fig. 
3-10). Cell ahesion to ECM proteins was correlated with Matrigel invasion in 4 o f the 6
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cell lines (See Table 1 Summary o f HNSCC Phenotypes, p.54). Interestingly, cell 
adhesion to fibronectin was correlated with Matrigel invasion in 5 o f  6 cell lines.
Cell adhesion to ECM proteins such as type IV collagen, fibronectin, and laminin 
is mediated by cell surface integrin receptors. Integrins bind ECM proteins by 
recognizing specific peptide sequences (30). For example, fibronectin and other ECM
Fig. 3-10 HNSCC cell adhesion to ECM proteins. Cell adhesion assay 
was performed as described in Materials and Methods. The results are the 
means (bars, SE) of two independent experiments, with a total of six replicates. 
EVSCC14M, 17M, 19M and UMSCC10A are more adhesive to ECM proteins 
than EVSCC18 and FaDu. The difference between two groups was significant 
(P<0.001).
proteins contain arginine-glycine-aspartic acid (RGD) sequences that serve as binding 
sites for integrin receptors (30). To demonstrate the specificity and biological relevance
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o f  cell adhesion to ECM proteins, cells were treated with a synthetic RGD peptide at 
various concentrations to test for the capacity to competitively inhibit cell adhesion.
In initial experiments, we tested the efficiency o f a synthetic RGD tripeptide to inhibit 
EVSCC17M cell adhesion to collagen type IV, fibronectin, or laminin (Fig. 3-11). A 
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Fig. 3-11 Inhibition of EVSCC17M adhesion to ECM proteins by RGD 
tripeptide. Cells were preincubated with RGD peptide 30 before the adhesion 
assay. The adhesion assay was performed in 96 well tissue culture plates 
coated with 100 ng/ml ECM proteins as described in Material and Methods 
section. The data represents the mean (bar, SE) of two independent 
experiments. Statistical analysis showed that the difference between the 4 mM 
NP peptide and 4mM RGD tripeptide treatment was significant (p<0.05).
negative control. NP peptide (4mM) had no effect on EVSCC17M adhesion to ECM 
proteins. RGD tripeptide inhibited EVSCC17M cell adhesion to fibronectin and laminin 
in a dose dependent manner. However, the inhibition was not very potent and required 
high concentrations o f  RGD (4mM) (Fig.3-11). The RGD tripeptide had no effect on 
EVSCC17M cell adhesion to Type IV collagen (Fig.3-11). Since cell adhesion to
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fibronectin is correlated with the invasive phenotype in most o f  HNSCC cell lines, we 
then tested the capacity o f a fibronectin-specific recognition RGD peptide (GRGDS) to 
inhibit EVSCC17M cell adhesion to fibronectin. A RGE peptide (GRGES) was used as a 
negative control. Peptide GRGDS inhibited EVSCC17M adhesion to fibronectin in a 
dose-dependent manner, whereas the control RGE peptide had no effect (Fig.3-12). 
GRGDSP peptides were more potent competitive inhibitors o f adhesion to fibronectin 
than RGDESP tripeptides ( compare Fig.3-12 and Fig. 3-11).
BSA. 100 ng/ml 
::t . z  Fn. 10 pg/ml
Fn & RGD or RGE. 0 5mM 
Fn & RGD or RGE. 1 mM
:------■ Fn & RGD or RGE. 2mM
  _ ■ ■  Fn & RGD or RGE. 4mM
illili
DRGESP GRGDSP
Fig. 3-12 Effect of peptides GRGDSP and GRGESPon EVSCC17M 
adhesion to fibronectin. Cells were preincubated with peptide 30 minutes 
before the adhesion assay. The adhesion assay was performed in 96 well 
tissue culture plates coated withlOO pg/ml fibronectin (Fn) as decribed in 
Material and Methods section. The data represents the mean (bar, SE) of 
two independent experiments. Statistical analysis showed that difference 
between RGD and RGE peptide treatment was significant (p<0.001).
In summary, we have characterized the invasive phenotype o f  HNSCC cell lines 
by evaluating Matrigel invasion, cell migration, cell adhesion, and MMP/TIMP 
production. (Table 1). HNSCC cell lines showing high invasion and motility 
(EVSCC14M, EVSCC17M) or weak invasion and reduced motility (EVSCC18,
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EVSCC19M. UMSCC10A. FaDu) were identified. In vitro adhesion assays showed a 
differential adhesion of HNSCC cells to ECM proteins and HNSCC cell adhesion to 
fibronectin was RGD dependent. Gelatin zymography and western blot analysis


















EVSCC14M + + + - + + high
EVSCC17M + + + + +/- + high
EVSCC18 - - + + + - weak
EVSCC19M - - - + - + weak
UMSCC10A - - - + - + weak
FaDu +/- +/- - - - - weak
Key findings: 1) Matrigel invasion and enhanced migration are closely linked.
2) Enhanced MMP-2 secretion, but not MMP-9, is associated with 
invasive potential.
3) Cell adhesion to ECM proteins may be necessary but is not sufficient 
for in vitro invasion.
4) TIMP-2 secretion is not associated with Matrigel invasion.
demonstrated a differential secretion o f 72kD and/or 92 kD type IV collagenase (MMP- 
2 and/or MMP-9) by HNSCC cell lines. Matrigel invasion was associated with cell 
adhesion to ECM proteins in 4 o f  6 cell lines and was correlated with MMP-2 secretion in 
5 o f 6 cell lines. TIMP-2 secretion did not correlate with Matrigel invasion, suggesting 
that alterations o f MMP-2 rather than TIMP-2 are important in generating the invasive 
phenotype of HNSCCs.
3-2 Determine the degree to which MMP production and migration may be regulated by 
cell- ECM interactions
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a. Determine the role o f cell-ECM interaction in regulation o f MMP production by 
HNSCC cell lines.
Cell adhesion to the ECM represents the initial step in the process o f  tumor invasion. 
Tumor cell-ECM interaction is hypothesized to stimulate MMP secretion and/or 




Fig. 3-13 Effects of ECM protein on MMP production by HNSCC cell lines.
Cells were treated with 10, 20, 40,or 80 ng/ml of fibronectin or laminin for 
24 hours, and MMP activity in CM was assessed by gelatin zymography 
as described in Materials and Methods. Shown is a representative zymogram 
of CM from EVSCC17M, EVSCC14M and EVSCC18. The Mr 92,000 and 
72,000 MMP activities are indicated (kD).
cells from the primary tumor site. We have shown previously that highly invasive 
HNSCC cells constitutively produced MMP-2 at high levels (Section 3-lb). However. 
MMP-2 secretion may be required but not sufficient for acquisition o f  the invasive 
phenotype. We hypothesize that cell binding to ECM proteins promotes secretion and 
activation of latent MMP-2 thus facilitating degradation of the basement membrane.
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Highly invasive (EVSCC14M. EVSCC17M) and weakly invasive EVSCC18 cells were 
used to examine the effect o f  cell adhesion to ECM proteins on MMP secretion and/or 
activation. Cells were harvested, resuspended in serum-free growth medium with ITS. 
plated in 24 well tissue culture plates and adherent cells treated with serum-free media 
containing 10. 20. 40. or 80 pg/ml o f either type IV collagen, fibronectin or laminin for 













■ Fa 10 ug/mi
□ Fa 20 ug.ml
□ Fa 40 ug/ml
■ Fa 80 ugAnl
■  Laminin. 10 ug/ml
■  Laminin. 20 ug/ml
□ Laminin. 40 ug/ml
■ Laminin. 80 ug/ml
EVSCC14M EVSCC17M EVSCC18
Fig. 3-14 Quantitative densitometry of MMP-9 production following 
treatment with fibronectin and laminin. Cells were treated with fibronectin 
(Fn) and laminin at various concentrations for 24 hours, and MMP activity 
was measured by gelatin zymography. MMP-9 activity was quantitated by 
Kodak Digital Science 1D™ software program.
controls. CM was collected for gelatin zymography and analyzed for secretion of latent 
and activated forms o f MMP-2/ MMP-9. The results are shown in Fig.3-13 and 
displayed quantitatively in Fig. 3-14. BSA had no effect on MMP production (data not 
shown). Fibronectin stimulated MMP-9 production by EVSCC14M and EVSCC17M in a 
dose-dependent manner. However, MMP-9 secretion by EVSCC18 cell was only seen at 
the higher doses o f  fibronectin (Fig. 3-13 and Fig.3-14). Furthermore, higher doses o f o f
Reproduced  with permission of the copyright owner. Further reproduction prohibited without permission.
57
fibronectin (40 ug/ml and 80 pg/ml) resulted in the secretion o f activated forms o f MMP- 
9 visualized as a more rapidly migrating band o f 84 kD (Fig. 3-13). In contrast to the 
stimulation o f MMP-9 secretion, fibronectin had minimal effects on MMP-2 secretion by 
all cell lines assessed (Fig. 3-13 ). Laminin had no effect on MMP-2 production by any of 
the cell lines but did appear to weakly stimulate MMP-9 secretion by EVSCC17M (Fig. 
3-14). Low doses o f collagen type IV had no effect on MMP production by HNSCC cell 
lines (data not shown); however, higher doses of type IV collagen (40 pg/ml) inhibited 
MMP production. (Fig. 3-15).
EVSCC14M  EVSCC18 EVSCC17M
MMP-9"^
MMP-2-*
EVSCC14M  EVSCC18 EVSCC17M
Fig. 3-15 Effect of ECM proteins on MMP production by HNSCC cell lines. Cells 
were treated with 40 pg/ml of ECM proteins for 24 hours, and MMP activity in CM 
was assessed by gelatin zymography as described in section 2.2. The upper panel 
is a representative zymogram. The lower panel is the quantitative densitometric 
analysis of the zymogram by Kodak digital science program.
b. Regulation o f HNSCCs migration by cell-ECM interaction
Cell-ECM interactions not only modulate MMP production but also regulate cell
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Fig. 3-16 Effect of fibronectin on cell migration of HNSCC cell lines. The 
migration assays were performed in modified Boyden chambers using various 
concentrations of fibronectin as chemoattractant as descibed in section 2.
The results are mean (bar, SE) number of migrated cells per high power field 
(400X) from two independent experiments. The difference between cells 
treated with 10-40 pg/ml of fibronectin versus BSA treatment was significant 
for EVSCC14M and EVSCC17M (P<0.001) but not for EVSCC18 (P>0.05).
migration. Several ECM glycoproteins, including vitronectin, fibronectin. laminin. and 
type IV collagen have been found to stimulate locomotion in different types o f tumor
BSA. 10 0  ug/ml 
Laminin.  1 ug/m l 
Laminin.  10 ug/ml 
Laminin.  20 ug/m l 
Laminin.  40  t»g/ml 
Laminin. 80 (ig/ml
EVSCC14M EVSCC17M EVSCC18
Fig. 3-17  Effect of laminin on cell migration of HNSCC cell lines. The migration 
assays were performed in modified Boyden chambers using various concentrations 
of laminin as chemoattractant as descibed insection 2. The results are mean 
(bar, SE) number of migrated cells per highpower field (400X) from two independent 
experiments. The difference between cells treated with 20-80 pg/ml laminin versus 
he BSA treated group was significant for EVSCC14M and EVSCC17M cells (P<0.001) 
but not for EVSCC18 (P>0.05).
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cells (14-17). To test the hypothesis that ECM proteins might regulate migration of 
HNSCC cells, we performed cell migration (chemotaxis) assays in the presence or 
absence o f different concentrations o f soluble ECM proteins as chemoattractants. The 
effects o f fibronectin, laminin, or collagen type IV on migration o f EVSCC14M. 
EVSCC17M and EVSCC18 cells are shown in Fig. 3-16. 3-17, and 3-18 respectively . 
Without any chemoattractant (BSA control), EVSCC14M and EVSCC17M cells were 
highly motile, whereas EVSCC18 cells were poorly motile (P<0.0001). Fibronectin and
Fig. 3-18  Effect of collagen type IV on cell migration of HNSCC cell lines.
The migration assays were performed in modified Boyden chambers using 
various concentrations of type IV collagen as chemoattractant as descibed in 
section 2. The results are mean (bar, SE) number of migrated cells per high 
power field (400X) from two independent experiments. The difference between 
cells treated with 20 pg/ml collagen type IV versus the BSA control was 
significant for EVSCC14M and EVSCC17M (P<0.001) but not for EVSCC18 
fP>0.05T
laminin stimulated EVSCC14M and EVSCC17M cell migration dose- dependently 
(P<0.0001). whereas neither protein stimulated EVSCC18 chemotaxis, Low to 
intermediate doses o f fibronectin (1 pg/ml to 40pg/ml) stimulated cell migration of
M M  B S A .  1 0 0  f ig /m l
C o l l a g e n  IV. 1 u g /m l  
C o l l a g e n  IV. 10 u g / m l
M M  C o l l a g e n  IV. 2 0  u g / m l  
i i C o l l a g e n  IV. 4 0  u g / m l
o
EVSCC14M EVSCC17M EVSCC18
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EVSCC17M and EVSCC14M cells, whereas a higher dose (80 fig/ml) was ineffective in 
stimulating cell migration (Fig.3-16). This biphasic stimulation o f cell migration was not 
observed with laminin (Fig.3-17). Collagen type IV also stimulated cell migration of 
EVSCC14M and EVSCC17M cells but not EVSCC18 (Fig.3-18). However, although cell 
migration o f EVSCC14M by collagen type IV exhibited a dose-dependent effect, 
stimulation o f EVSCC17M cell migration by collagen type IV was restricted to a dose o f 
20 pg/ml.
■ ■ ■ i BSA. 100 ug /m l 
— - Fn. 30 ug /m l
Fn & R G D  or  R G E .  0 5mM 
k s b  Fn & R G D  or  R G E .  1mM 
Fn & R G D  o r  R G E .  2mM 
Fn & R G D  o r R G E .  4mM
GRGES GRGDS
Fig.3-19 Effect of RGD or RGE peptide on EVSCC14M migration in response to 
fibronectin. Migration assays were performed as described in section 2.1 
using 30 pg/ml fibronectin (Fn) as chemoattractant Cells were pretreated with 
RGD or RGE peptide at concentrations indicated in figure legend. The results 
are mean (bar, SE) number of migrated cells per high power field from at least 
two independent experiments. GRGDS inhibited cell migration dose-dependently. 
The difference between RGD treatment and RGE treatment to inhibit Fn-stimulated 
migration was statistically significant (P<0.001).
To determine the specificity o f cell adhesion to ECM proteins on cell migration. 
EVSCC14M and EVSCC17M cells were pretreated with RGD peptide, GRGDS. which 
is predicted to block cell surface integrin binding sites to fibronectin and thus inhibit the 











Reproduced  with permission of the copyright owner. Further reproduction prohibited without permission.
served as a negative control. The migration assays were performed using 30 pg/ml of
fibronectin as the chemoattractant. Cell migration without chemoattractant was used as
baseline. As expected. EVSCC14M and EVSCC17M were highly motile in the absence
of chemoattractant (Fig. 3-19 and Fig.3-20). Treatment o f  cells with 30 pg/ml of
fibronectin increased EVSCC14M and EVSCC17M cell migration by 1.5-2 fold
(P<0.01). GRGDS peptide inhibited EVSCC14M and EVSCC17M cell migration dose-
dependentlv (P<0.001). whereas GRGES had no inhibitory effect (Fig 3-19 and Fig. 3-
20 ).
BSA. 100 pQ/mt 
,_z:_ Fn. 30 pg/m!
M M  Fn & RGD or RGE. 0 5mM 
■ ■ i  Fn & RGO or RGE. 1 fn M 
Fn A RGO or RGE. 2mM 
^ ^ B  Fn & RGD or RGE. 4mM
GRGES GRGDS
Fig.3-20 Effect of RGD or RGE peptide on EVSCC17M migration in response 
to fibronectin. Migration assays were performed as described in section 2.1 
using 30 ug/ml fibronectin (Fn) as chemoattractant. Cells were pretreated with 
RGD or RGE peptide at concentrations indicated in figure legend. The results 
are mean (bar, SE) number of migrated cells per high power filed (400X) from 
at least two independent experiments. GRGDS inhibited cell migration 
dose-dependently. The difference between RGD treatment and RGE treatment 
to inhibit Fn-stimulated migration was statistically significant (P<0.001).
3-3. Determine the role o f  MMPs in invasion o f HNSCC
Proteolytic degradation o f the ECM is an important step in tumor invasion. The 
data presented in section 3.1 showed that MMP-2 production was associated with
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Matrigel invasion by EVSCC14M cells. Because increased expression o f  MMPs by
malignant tumor cells is believed to play an essential role in invasion, we hypothesized
that MMP-2 production was necessary for the invasion o f HNSCC cells. To test this
hypothesis, we assessed the effect o f  antibody specific for MMP-2 on the invasive
potential o f  EVSCC14M cells. We reasoned that if MMP-2 production was necessary
for. and not simply correlated with, the invasive potential o f head and neck tumor cells.
then neutralization o f  MMP-2 activity should block in vitro invasion o f  EVSCC14M
cells.
EVSCC14M Cells were treated with polyclonal antibody to MMP-2 or normal rabbit
serum and assessed for Matrigel invasion. Normal rabbit serum had no effect on Matrigel
invasion by EVSCC14M. Neutralizing antibody to MMP-2 inhibited EVSCC14M cell
invasion dose-dependently. The maximum inhibition was greater than 50% (P<0.001) at
a dose o f lOOjig/ml (Fig.3-21).
xoo'T
Dosage of anti MMP-2 antibody
Fig. 3-21 Dose dependent inhibition of Matrigel invasion of EVSCC14M by antibody 
to MMP-2. Invasion assays were conducted with Matrigel coated 8 um-pore size 
polycarbonate membranes in a modified Boyden chamber. Various concentrations 
of anti-MMP-2 antibody were added to the upper chamber and invasion was 
measured after 5 hours exposure to 3T3 CM. The results are mean number (bar, 
SE) of invaded cells per high power field (HPF) with 400X magnification. Antibody 
significantly inhibited matrigel invasion by EVSCC14M (P<0.001).
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3-4. Calcium-dependent signaling and the invasive phenotype of HNSCCs
Accumulating data have demonstrated that integrin-mediated cell-ECM 
interactions are important in the regulation o f  a variety o f cell functions including cell 
migration and MMP production (49,82). A common regulatory point in several integrin 
signaling pathways is intracellular calcium homeostasis. Calcium represents a signaling 
molecule essential in many signal transduction pathways and is known to regulate a 
number o f biochemical processes, including cell proliferation, invasion, angiogenesis.
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Fig. 3 -22  Effect of CAI on agonist-induced elevation of[Ca2*] in 
EVSCC17M and FaDu cells. EVSCC17M and FaDu cells were 
loaded with Fura-2 and preincubated with 20 uM CAI for 30 min 
before agonist [ EGF(200ng/ml) and bradykinin (1 (o.M ) ] addition, 
indicated by arrow. Untreated cells were incubated with an 
equivalent amount of DMSO vehicle.
and secretion (125). To investigate if calcium-dependent signaling pathways were 
important in the biology of HNSCC. we made use o f a novel inhibitor o f  calcium influx.
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carboxyamido-triazole (CAI). that selectively blocks calcium-mediated signal 
transduction events (126). Previous reports have shown that CAI inhibited the 
proliferation and invasive behavior o f malignant cells in vitro and in animal tumor 
models (119.121.127). However, the effect of CAI on the proliferation and invasiveness 
o f head and neck tumor cells was not known. We first evaluated the effect o f CAI on 
calcium influx in EVSCC17M and FaDu cells treated with two general calcium agonists, 
epidermal growth factor (EGF) and bradykinin. Using cells loaded with the calcium 












Vehicle 2 5 10
CAI Dosage (pM)
Fig. 3-23 D ose-dependent effect o f  CAI on Matrigel invasion by 
EVSCC14M . Cells were treated with different dosages o f  CAI and 
M atrigel invasion was perform ed as described in “M aterials and 
M ethods” . The results are the mean (bar, SE) o f  two independent 
experim ents w ith six replicas. The difference between CAI treated and 
untreated group w as statistically significant (P<0.001).
EVSCC17M and FaDu cells treated with EGF and bradykinin, respectively (Fig.3-22). 
The EGF effect on calcium in EVSCC17M cells was dose-dependent and was attenuated 
>70% by EGTA in the assay buffer, indicating a significant calcium influx component 
involved with calcium mobilization by EGF in HNSCC cells (data not shown).
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Preincubation with 20 pM CAI markedly attenuated calcium elevation in both cell lines 
(Fig. 3-22 A and B). Similar results were obtained with other agonists (data not shown), 
confirming that CAI blocks agonist-induced calcium influx in HNSCC cells. We also 
examined the dose dependency o f  CAI to attenuate bradykinin induced elevations o f 
intracellular free calcium. CAI at a concentration o f 1 pM produced a 10% inhibition, 
whereas 10 pM CAI produced a maximum 50% inhibition ( data not shown). Increasing 
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Fig.3-24 Effect o f  CAI on invasive potential o f  HNSCC cell lines. Invasion assays were 
conducted with M atrigel-coated 8 um pore size polycarbonate m em branes in a modified 
Boyden cham ber. Cells were exposed to medium without or with 10 uM CAI for 18 hours 
prior to and during the assay. Invasion was measured after 5 hr exposure to 3T3 conditioned 
medium. Cells on the underside o f  the membrane were stained and counted by an image 
analyzer. Results are the mean + /- SE o f  2 independent experiments with total o f  6 
replicates. Inset: expanded scale o f  HNSCC cells with weak invasive potential. M ixed model 
o f  Nested ANOVA was perform ed with assistance o f  Instat2 software. D ifferences between 
the high and low invasive cell lines are significant (p<0.05). Treatment o f  CAI significantly 
reduced the invasive potential o f  all cell lines (P<0.05) except EVSCC19M .
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We then tested the effects o f  CAI on Matrigel invasion, cell migration, and MMP 
production by HNSCC cell lines. In preliminary experiments, we determined that the 
effects o f CAI on parameters o f invasion were dose-dependent with half-maximal 
inhibitory concentrations (IC50s) between 3 and 10 uM (Fig.3-23) and used 10 uM CAI
2 0 0 0  -i C ontro l
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Fig.3-25  Effect of CAI on migration of HNSCC cell lines. Migration assays were 
performed as described for the chemoinvasive assay, except that polycarbonate 
membranes were coated with gelatin. The results are the means (bars, SE) of two 
independent experiments. Inset, expanded scale of HNSCC cells with reduced 
motility. Statistical analysis demonstrated that CAI significantly inhibited cell 
migration of cell lines (P<0.05).
in subsequent experiments. Treatment o f HNSCC cells with CAI for 24 hours blocked 
Matrigel invasion and cell migration 2-14 fold (Fig. 3-24 & 3-25) and inhibited MMP-2 
production 3-7 fold (Fig. 3-26 & 3-27) relative to untreated control cells. CAI inhibited 
in subsequent experiments. Treatment o f HNSCC cells with CAI for 24 hours blocked
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Matrigel invasion and cell migration 2-14 fold (Fig. 3-24 & 3-25) and inhibited MMP-2 
production 3-7 fold (Fig. 3-26 & 3-27) relative to untreated control cells. CAI inhibited
MMP-2 72 kD
Fig.3-26 Effect of CAI on MMP production by HNSCC cells. Cells were treated without(-) 
or with (+) 10 pM CAI for 24 h, and MMP activity in CM was assessed by gelatin 
zymography. Shown is a representative zymogram of CM from EVSCC19M,EVSCC14M 
and EVSCC18. CM from HT1080 was used as a positive control for MMP-9 and MMP-2 
activity. The Mr 92,000 and 72,000 MMP activities are indicated (kD).
MMP-2 (72 kD) MMP-9 (92 kD)
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Fig. 3-27 Quantitative densitometry of MMP production by HNSCC ceil 
lines. Cells were treated without or with 10uM CAI for 24 hr and MMP 
activity of conditioned medium assessed by gelatin zymography as 
described in “ Materials and Methods”. MMP activity was quantitated by 
densitometnc scanning of individual lanes and expressed as net intensity.
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MMP-9 secretion less effectively (~1.5-fold reduction). Collectively, the data 
demonstrate that calcium signaling is an important determinant o f the invasive 
phenotype.
3-5 The role o f focal adhesion kinase in the regulation o f MMP production and 
expression o f the invasive phenotype o f HNSCCs
We have demonstrated that inhibition o f calcium influx inhibited the invasive 
potential o f  HNSCCs in vitro (78). Work of others has shown that inhibition of calcium 
influx blocked FAK phosphorylation and kinase activity (89). Since activation o f FAK 
has been functionally linked to the focal adhesion site and generation o f signals for 
motility and invasion (80). we assessed the role o f FAK in regulation o f MMP production 
and expression o f the invasive phenotype o f HNSCCs. To achieve this goal, we first 
assessed expression and phosphorylation of FAK in HNSCC cell lines and then further 
dissected the role o f FAK in generation o f the invasive phenotype by transfection studies.
a. Expression and phosphorylation o f FAK and invasiveness o f HNSCCs
To assess FAK expression and phosphorylation, lysates from three moderately to 
highly invasive HNSCC lines (EVSCC14M, EVSCC17M, A431) and two weakly 
invasive cell lines (EVSCC18. FaDu) were immunoprecipitated with anti-FAK antibody. 
Since FAK is a natural substrate o f src tyrosine kinase, lysates from Rati transfectants 
overexpressing src (Rati src cells) served as a positive control. FAK immunoprecipitates
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were blotted with anti FAK antibody to assess FAK protein levels or antiphosphotyrosine 
antibody (RC20) to assess FAK phosphorylation. Rati Src cells constitutively expressed 





Fig.3-28 Immunodetection of p125FAK and phosphorylation of p125FAK in 
HNSCC cell lines. Cell lysates (800 pg protein) from near confluent HNSCC 
and control cell lines were immunoprecipitated (IP) with anti-FAK antibody 
and western blots probed with anti-FAK antibody or anti-phosphotyrosine 
antibody RC20). Shown is an example of an immunoblot demonstrating 
expression of p125FAK (upper panel) and the basal level of activated FAK 
(lower panel) in HNSCC cell lines. R1-Src are rati ceils transformed by v-src.
Basal levels o f FAK expression varied ~3-fold between the cell lines (Fig. 3-28) with no 
apparent correlation with the invasive phenotype. Interestingly, levels o f  phosphorylated 
FAK were correlated with invasion and cell migration. By densitometric scanning, the 
moderately to highly invasive cell lines (EVSCC14M, EVSCC17M, A431) exhibited 2 to
4-fold more phosphorylated FAK than the weakly invasive EVSCC18 or FaDu cells (Fig. 
3-29). The findings support a role for FAK activation in regulation o f  cell migration and 
invasion.
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Fig. 3-29 Quantitative densitometry of FAK expression and basal levels of 
phosphorylation of FAK in HNSCC cell lines.
b. Role o f FAK in expression o f the invasive phenotype of HNSCCs by modulation o f 
FAK expression and phosphorylation
We demonstrated that levels o f  phosphorylated FAK were correlated with cell 
migration and Matrigel invasion suggesting that FAK signaling may be involved in 
expression o f the invasive phenotype o f HNSCCs. To further dissect the role o f FAK 
signaling in generating the invasive phenotype o f HNSCC, sense or antisense FAK 
cDNA as well as the carboxy-terminal isoform, FAK-related non-kinase (FRNK) were 
expressed by stable transfection o f selected HNSCC cell lines. Modulation of FAK or 
FRNK expression was confirmed by immunoblotting and transfectants assessed for 
invasive potential.
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I . Generation o f  FAK and FRNK expression plasmids
FAK and FRNK cDNA from Bluescript phagemids were cloned in pSV.Sport 1 in 
both the sense and antisense orientation. Sense and antisense FAK expression vectors 
were verified by restriction digestion with Dral. As predicted, restriction analysis o f sense
1 2 3 4 5 6
Fig. 3-30 Restriction analysis of sense and antisense FAK expression 
vectors. Sense and antisense expression vectors were digested with Ora 
I. pSK.FAK and pSV. Sportl were used as controls. Lanel is 1 Kb DNA 
marker Lane 2 is pSK.FAK, Lane 3 and Lane 6 is pSV. FAK. Lane 4 is 
the antisense FAK expression vector pSV aFAK. Lane 5 is pSV Sportl.
FAK expression vector with Dra I generated 2899, 1430, 1420, and 692 bp fragments, 
whereas restriction digestion o f the antisense FAK with the same enzyme resulted in 
2634. 962. and 247 bp fragments (Fig. 3-30). Sense and antisense FRNK expression 
plasmids were verified by restriction digestion with Hind III. Restriction digestion o f
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sense FRNK with Hind III generated 3.98 kb and 280 bp fragments, whereas restriction 
digestion o f antisense FRNK resulted in 3.3 kb and 904 bp fragments (Fig.3-31).
I  ___
1 2 3 4 5
Fig. 3-31 Restriction analysis of sense and antisense FRNK constructs. 
pSV. FRNK and pSV.a FRNK were digested with Hind III. PSK.FRNK 
was used as control. Lanel is 1 Kb DNA molecular marker. Lane 2 and 
Lane 4 is pSK. FRNK cDNA. Lane 3 is the antisense FRNK expression 
vector. Lane 5 is sense FRNK expression vector.
II. Transfection, selection and verification o f  FAK or FRNK expression and 
phosphorylation by immunoblolting and immunoprecipitation
Weakly invasive cell lines with low levels o f FAK expression (EVSCC18) or 
highly invasive lines with elevated levels o f FAK expression (EVSCC14M, EVSCC17M) 
were used for DNA transfection (Table 2). Because polybrene had been used successfully 
in our laboratory to introduce the EMS1 gene into 3T3 cells, initial experiments 
concentrated on cotransfection o f sense FRNK with pSV2.neo into EVSCC14M cells 
with polybrene. After three attempts with this method using various ratios o f pSV2.neo
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Table 2: Invasive and FAK phenoype of cell lines used for transfection
EVSCC14M EVSCC17M EVSCC18
Matrigel invasion High High Weak
Enhanced motility + + -




to pSV.FRNK. 38 colonies were obtained following G418 selection and clonal 
expansion. None o f  the G418 resistant clones overexpressed FRNK protein assessed in 
cell extracts by western blot analysis with FAK antibody BC3, a polyclonal antibody 
recognizing a carboxyl terminal FAK epitope (Table 3). Because the transfection 
efficiency by polybrene was low (<1%) for HNSCC cells, we evaluated a number o f 
different methods and reagents in an effort to achieve optimal transfection efficiency. 
Techniques assessed for transfection efficiency included polybrene, calcium phosphate 
precipitation, liposome-mediated transfection ( Tfx™, Promega, Madison, WI), Superfect 
(Qiagen. Valencia. CA), and FuGene 6 (Boehringer Mannheim, Indianapolis, IN). Using 
these transfection reagents and protocols provided by each manufacturer, we transfected a 
P~gal plasmid or pSV2.neo plasmid into HNSCC cell lines to assess transient and stable 
transfection efficiency, respectively. By this comparative analysis, we found that FuGene 
6 reagent gave the highest transfection efficiency for most cells tested (data not shown). 
Therefore, we used the FuGene 6 reagent for subsequent DNA transfections. 
Cotransfection o f sense FRNK with pSV2.neo into EVSCC14M or EVSCC17M cells
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resulted in 18 and 13 stable transfectants, respectively. Immunoblotting analysis 
identified 3 o f 18 EVSCC14M transfectants that overexpressed FRNK protein (Table3;













FRNK/neo Polybrene/ 38 0
(10-30:1) DMSO
FRNK/neo FuGene 6 18 3
(10:1)
aFA K 2/neo FuGene 6 8 2
(10:1)
FRNK/neo FuGene 6 13 6
(20:1)
aFA K 2/neo FuGene 6 18 2
(20:1)
FAK/neo FuGene 6 11 5
(20:1)
* Assessed by immunoblotting with FAK antibody BC3. 
2 aFAK: antisense FAK
Fig. 3-32) and 6 o f 13 EVSCC17M transfectants that overexpressed FRNK (Table 3). 
Sense FAK and pSV2.neo cotransfection of EVSCC18 cells generated 11 stable 
transfectants. of which 5 over-expressed FAK protein assessed by immunoblotting with 
FAK antibody (Table 3, Fig. 3-39). A similar approach was used to introduce antisense 
FAK into EVSCC14M and/or EVSCC17M, two HNSCC cell lines that exhibit high 
levels o f FAK expression and phosphorylation and are highly invasive (Table 2). Two 
clones in each group were identified that expressed decreased levels o f FAK (30% to 
50% reduction as compared to neo control (Table 3). EVSCC14M (antisense FAK)
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and EVSCC17M (antisense FAK) transfectants were not studied further.
III. Assess the invasive phenotype o f FAK and FRNK transfectants.
1. Invasive phenotype of FRNK transfectants
Data presented in section 3.5a demonstrated that FAK phosphorylation was 
associated with the invasive phenotype o f HNSCC cell lines, suggesting that FAK 
activation may contribute to the invasive potential o f  HNSCCs. To further investigate the 
role o f FAK activation in regulation o f tumor invasion, we overexpressed FRNK in
p125FAK
P41/43FRNK
Fig.3-32 Overexpression of FRNK in EVSCC14M cells by transfection.
FRNK expression plasmids were transfected into EVSCC14M as 
described in the Materials and Methods section. pSV.neo alone was 
transfected into EVSCC14M cells as a negative control. NIH3T3 cells 
transiently transfected with FRNK served as a positive control. Cell 
lysates were analyzed by immunoblotting with FAK antibody BC3 for FAK 
and FRNK expression. 125 kD FAK and 41/43 kD FRNK are indicated.
EVSCC14M by transfection in an effort to inhibit FAK phosphorylation. Western blot
analysis showed that three FRNK clones (FRNK1, FRNK2, FRNK11) overexpressed
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FRNK by 5-7 fold as compared to neo control clones, whereas FAK level was not altered 
by FRNK transfection (Fig.3- 32).
To assess the effect o f  FRNK expression on FAK phosphorylation in EVSCC14M 
FRNK transfectants. lysates from two clones pSV.FRNKl and pSV.FRNK2 were 
immunoprecipitated with BC3 antibody and probed with BC3 for FAK and FRNK
protein expression, and RC20 antibody for FAK phosphorylation. EVSCC14M pSV.neol 







/  ^  ̂  A/  
* / /  *
Fig. 3-33 Effect of FRNK expression on FAK phosphorylation in EVSCC14M 
FRNK transfectants and controls. Cell lysates from FRNK or neo control clones 
were immunoprecipitated with BC3 antibody. The immunocomplexes were 
probed with BC3 for FAK and FRNK expression and probed with RC20 
antiphosphotyrosine antibody for FAK phosphorylation.
in pSV.FRNKl and FRNK2 transfectants as compared to neol and neo2 controls (Fig. 3- 
33. lower panel). Expression o f FRNK slightly reduced FAK expression but inhibited
R eproduced  with permission of the copyright owner. Further reproduction prohibited without permission.
Fig. 3-34. Photomicrography of Matrigel invasion by EVSCC14M FRNK 
transfectants and controls. Chemoinvasion assays were performed in 
modified Boyden chambers as described in section2.1. Photograph was 
taken under 400 X magnification. A. pSV2.neo1 14M. B. pSV2.neo2.14M 
C. pSV.FRNKl. 14M. D. pSV.FRNK2.14M
FAK phosphorylation greater than two fold (Fig3-33. middle panel). To characterize the
Fig.3-35 Matrigel invasion by EVSCC14M FRNK transfectants and controls. Invasion 
assays were conducted with Matrigel-coated 8 nM- pore size polycarbonate membranes 
in a modified Boyden chamber and was measured after 5 hours of exposure to 3T3 
conditioned medium.Cells on the underside of the membrane were stained and counted 
manually with 400X magnification. Data are represented as the number of invaded cells 
per high power field (HPF). Results are means (Bars, SE) of two independent 
experiments, with a total of six replicates. Statistical analysis showed a significant 
difference in invasion between neo controls and FRNK transfectants (P<0.05).
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invasive phenotype o f  EVSCC14M FRNK transfectants, Matrigel invasion assays were 
performed using 3T3 CM as chemoattractant. Unexpectedly, FRNK overexpression 
increased the invasive potential o f EVSCC14M approximately 50% as compared to neo 
controls (p<0.05) (Fig. 3-34 and Fig.3-35) but did not change overall cell morphology. 
Since MMP production is an important step in tumor invasion, we assessed MMP 
production by EVSCC14M FRNK transfectants by gelatin zymography. FRNK 
overexpression had very little effect on MMP-2 secretion, but promoted MMP-9 
production by 20-40% (Fig.3-36).
92kO, MMP-9 
72 kD, MMP-2
Fig. 3-36 MMP production by EVSCC14M FRNK transfectants and controls. 
Cells were incubated with serum-free ITS medium for 24 hours, CM were 
collected and MMP activity in CM was assessed by gelatin zymography as 
described in section 2.2. The upper panel is a representative zymogram. The 
lower panel is the quantitative densitometric analysis of the zymogram 
by Kodak digital science 1D software program.
To further investigate the invasive phenotype o f EVSCC14M FRNK 
transfectants, we assessed the motility o f the transfectants by the chemotaxis assay using 
3T3 CM or fibronectin as chemoattractants. FRNK transfectants were more motile than
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Fig. 3-37. Photomicrography of cell migration by EVSCC14M FRNK 
transfectants. Cell migration assays were performed in modified Boyden 
chambers with 30 fig/ml Fn as chemoattractant as described in section 2.1. 
Photograph was taken under 200 X magnification. A. pSV2.neo1 14M. B. 
pSV2.neo2.14M. C. pSV.FRNKl.14M. D. pSV.FRNK2.14M.
neo controls without chemoattractant. Similar to the parental cell line and neo control, 
migration o f FRNK transfectants was stimulated by fibronectin dose dependently. In
Fig.3-38 Cell migration of EVSCC14M FRNK transfectants. Migration assays were 
performed as described for the chemoinvasive assay, except that the polycarbonate 
membranes were coated with gelatin. Both 3T3 CM and fibronectin (Fn) were used as 
chemoattractants. Data are presented as the number of migrated cells per high power 
(HPF 400X). The results are the means (bars, SE) of two independent 
experiments.Statistical analysis demonstrated that FRNK significantly enhanced cell 
migration as compared to neo controls (P<0.05).
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response to the same dose o f fibronectin or 3T3 CM, FRNK transfectants were more 
migrative than neo controls CM (P<0.05) (Fig.3-37 and Fig.3-38).
2. Invasive phenotype o f EVSCC18 FAK transfectants
To assess directly the effect o f FAK overexpresion on the invasive phenotype o f 
HNSCC. we transfected FAK into the low FAK expressor and weakly invasive cell line. 
EVSCC 18. FAK overexpression in EVSCC 18 FAK transfectants was verified by 
western blot analysis using antibody to FAK. The blot was reprobed with antibody to
Actin
Fig.3-39 Overexpression of FAK in EVSCC18 cells by transfection.
Sense FAK and pSV2neo or pSV2.neo alone were transfected into 
EVSCC18 cells as described in Material and Methods. G418 resistant 
clones were expanded and cell lysates analyzed by western blotting with 
FAK antibody for FAK expression and reprobed with actin as an internal 
control for loading.
actin as an internal control for equal loading. Figure 3-39 illustrates FAK overexpression 
(2-4 fold) in EVSCC 18 FAK transfectants relative to the neo transfectant controls (Fig.3- 
39). EVSCC 18 FAK expression clones, pSV.FAK.4/18 and pSV.FAK.6/18 were selected
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as candidates for characterization o f the invasive phenotype assessed by Matrigel 
invasion, cell migration, and MMP secretion. Two neo clones, pSV.neol/18 and 
pSV.neo2/18 served as negative controls. In the absence of chemoattractants (BSA alone) 
EVSCC 18 FAK transfectants and neo controls were poorly invasive, similar to parental 
EVSCC 18 cells (Fig. 3-41). In the presence o f CM as the source of chemoattractants. 
EVSCC 18 FAK transfectant clones exhibited substantially greater Matrigel invasion 
relative to the neo controls ( Fig 3-40 and Fig. 3-41). This difference in Matrigel invasion
Fig. 3-40 Photomicrography of Matrigel invasion by EVSCC18 
FAK transfectants. Matrigel invasion assays were performed with 3T3 
CM as chemoattractant as described in section2.1. Photograph was 
taken under 200 X magnification. A. pSV2.neo1/18. B. pSV2.neo2/18.
C. pSV.FAK4/18. D. pSV.FAK6/18.
between the FAK transfectants and neo controls was most pronounced in the presence of 
fibronectin, which stimulated invasion in a dose-dependent manner (Fig. 3-41). Although 
enforced FAK expression significantly increased the invasive potential o f  EVSCC 18 
cells, the extent o f  Matrigel invasivion never reached the level o f highly invasive
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EVSCC 14M and EVSCC 17M cells (compare Fig3-41 with Fig 3-1). In addition, unlike 
EVSCC14M and EVSCC17M cells, we observed that EVSCC18 FAK transfectants 
appeared to clump together (Fig.3-40).
Fig. 3-41 Matrigel invasion by EVSCC18 FAK transfectants. Invasion assays were 
conducted with Matrigel-coated 8 nM- pore size polycarbonate membranes in a modified 
Boyden chamber and were measured after 5 hours of exposure to either 3T3 CM, BSA 
or fibronectin at 15 pg/ml or 30ug/ml. Cells on the underside of the membrane were 
stained and counted manually with 200X magnification. Data are represented as no. 
of invaded cells per well. Results are means (Bars, SE) of two independent experiments, 
with a total of six replicates. Statistical analysis showed that the difference between neo 
and FRNK transfectants was significant (P<0.01).
To study the contribution o f MMP2/MMP-9 to the increased invasive phenotype 
of FAK transfectants, we assessed MMP-2/MMP-9 secretion in CM  from EVSCC 18 
transfectants and neo controls by gelatin zymography. Both FAK transfectants and neo 
controls exhibited variable amounts o f MMP-2 secretion. O f interest, the more invasive 
pSV.FAK4/18 clone secreted 2-fold more MMP-2 that the less invasive pSV.FAK6/18 
clone or neo controls ( Fig. 3-42). MMP-9 secretion was increased by 3-4 fold in the 
CM of the two FAK transfectants compared to the extent o f  MMP-9 secretion in neo 
control clone (pSVneol) with the higher level o f  secretion (Fig.3-42). Cell motility o f
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EVSCC 18 FAK transfectants was assessed by chemotaxis using CM or fibronectin as 
chemoattractants. Cell motility o f  either EVSCC 18 FAK transfectants or neo controls 
was low without chemoattractants (BSA alone).
92kD, MMP-9 
72 kD, MMP-2
Fig. 3-42  MMP production by FAK transfectants. Cells were incubated in serum- 
free ITS medium for 24 hours. CM collected and MMP activity assessed by gelatin 
zymography as described in section 2.2. The upper panel is a representative 
zymogram of two experiments. The lower panel is the quantitative densitometric 
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Fig. 3-43 Cell migration of EVSCC18 FAK transfectants. Migration assays were 
performed as described in Materials and Methods. Either 3T3 CM or fibronectin were 
used as chemoattractants. Data are presented as number of migrated cells per well. 
The results are the means (bars, SE) of two independent experiments.Statistical 
analysis demonstrated that FAK overexpression significantly enhanced cell migration 
in response to CM or fibronectin as compared with neo controls (P<0.01).
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Conditioned medium or increasing doses o f fibronectin stimulated motility o f EVSCC 18 
neo controls to a limited extent, whereas CM or fibronectin potently stimulated motility 
o f both EVSCC 18 FAK clones (Fig.3-43). The pSV.FAK 6/18 clone, in particular, 
exhibited a robust increase in cell motility when stimulated with CM or increasing doses 
o f fibronectin (Fig. 3-43).




In the present study, we sought to identify and characterize determinants of 
invasion by head and neck tumor cells. Utilizing a panel o f  HNSCC cell lines previously 
established in our lab, we tested the application and relevance of the three-step 
hypothesis o f  tumor invasion to HNSCC and investigated the mechanism(s) pertaining to 
the regulation of each step in the invasive process. The results demonstrated that 1) tumor 
cell invasion by HNSCC is a complex process involving three repeated sequential steps: 
cell adhesion, proteolytic degradation o f the basement membrane, and migration; 2) 
MMP-2 production is essential for Matrigel invasion by HNSCCs; 3) MMP production 
and cell migration are regulated by integrin mediated cell-ECM interaction; and 4) 
Regulation o f MMP production and cell migration by cell-ECM interaction depends on 
calcium signaling and FAK activation.
4.1 Involvement of three sequential steps: Cell adhesion, proteolytic degradation, and cell 
migration in tumor invasion by head and neck tumor cells
Tumor invasion o f basement membranes is a crucial step for malignant 
dissemination and marks the beginning o f metastasis by HNSCCs. Therefore, the ability 
of the tumor cell to breach the basement membrane defines the invasive phenotype o f  a 
tumor (13). Experimental measurement of invasive potential is a challenging task. 
Previously, a variety of in vitro systems have been developed to assess the invasiveness
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of tumor ceils (128). Several o f  these assays utilized tissues containing basement 
membranes, such as the bladder wall (129), amnion (130), lens capsule (131) and chick 
chorioallantoic membranes (132). Disadvantages o f these approaches included the 
requirement o f fresh sample, uneven thickness o f the membrane, and the presence of 
microtears in the membrane that reduced the reproducibility o f the assay (133). 
Subsequent studies have used pressed disks composed o f lyophilized collagen type IV 
and laminin to test the invasiveness o f tum or cells in Boyden chambers (134). However, 
disks were fragile after reconstitution and difficult to handle. To improve the handling 
property, a porous membrane filter coated with Matrigel, a reconstituted mixture o f 
basement membrane proteins, was used to assess tumor invasion in different systems 
(133. 135). However, the original Matrigel assays required a long incubation time (72 
hours), which is complicated by the need to account for cell division and also increased 
the opportunity for bacterial contamination. In the present study, we used Matrigel- 
coated porous membrane filters in a modified Boyden chamber to test the invasive of 
HNSCC cells in a 5 hour assay. NIH 3T3 cell conditioned medium, which contains 
fibronectin. collagen (136), scatter factor (123), and other uncharacterized 
chemoattractants was placed in the lower well beneath the filter to stimulate chemotaxis. 
The 5 hour assay obviates the concerns o f cell division and microbial contamination that 
hampered the longer assays. Six head and neck cancer cell lines were evaluated for 
invasive potential by this method. The results demonstrated that HNSCC cell lines 
spanned the spectrum from highly invasive EVSCC 14M and EVSCC 17M cells to weakly 
or poorly invasive EVSCC 18, EVSCC 19M, FaDu, and UMSCC10A cells. This 
continuum of invasive potential in vitro recapitulates the biologic phenotype o f HNSCC
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in vivo and emphasizes the value o f cell lines as representative o f  the tumor o f origin. It 
is important to point out that HNSCC cell lines are remarkably stable in vitro, both 
cytogenetically and genetically, thus validating their use as experimental research models 
(137).
Active cell locomotion is an important step in tumor invasion. To further 
characterize the invasive phenotype, we assessed HNSCC cell lines for cell motility by a 
chemotaxis assay. The results showed that highly invasive cell lines (EVSCC14M and 
EVSCC17M) were also highly migratory whereas weakly invasive cell lines (EVSCC18. 
EVSCC19M, FaDu, and UMSCC10A) were less motile. Our results are consistent with 
previous reports o f other tumor cell types (138,139). The close relationship between cell 
motility and Matrigel invasion o f HNSCC cell lines suggested that cell migration plays 
an important role in the invasive process o f HNSCCs.
Proteolytic degradation o f the extracellular matrix is considered the rate-limiting 
step in tumor invasion. MMPs are a group o f zinc dependent proteases responsible for 
degradation o f extracellular matrix proteins. Studies in the past have shown that MMPs 
are involved in local invasion and distant dissemination o f a variety o f  tumors (38). Since 
MMP-9 and MMP-2 are two well characterized MMPs, we assessed MMP-2/MMP-9 
secretion into conditioned medium by gelatin zymography. HNSCC cell lines exhibited 
differential levels o f  MMP-2 activity. Densitometric analysis revealed that MMP-2 
secretion was correlated with Matrigel invasion by HNSCC cell lines. One notable 
exception was EVSCC18 cells, which secreted high levels MMP-2 but were poorly
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invasive. Further analysis showed that EVSCC18 cells were also weakly motile, 
suggesting that the low invasive potential o f EVSCC18 was due to impaired motility. In 
addition to MMP-2 secretion, HNSCC cell lines also secreted variable amounts o f MMP- 
9. However, we found that MMP-9 secretion was not correlated with Matrigel invasion. 
In contrast to our findings, other studies have demonstrated that MMP-9 production was 
required for Matrigel invasion (57). These divergent results from different laboratories 
likely reflect the heterogeneous nature of HNSCCs. Although our findings underscore 
MMP-2 as a critical determinant o f in vitro invasion, they do not exclude a role for 
MMP-9 in the pathogenesis o f HNSCC. For example, MMP-9 may target substrates 
other than Matrigel or may generate products that act as chemoattractants and thus 
influence cell behavior.
Gelatin zymography detects the enzymatic activity that degrades gelatin 
incorporated into a polyacrylamide gel. Therefore, the technique per se is not specific for 
the measurement o f MMP-9/MMP-2. Recently, calcium- and zinc-independent 
gelatinases were identified in human circulation that exhibited similar mobilities to 
MMP-9/MMP-2 in gelatin zymography (140) Thus, it is possible that gelatinase activity 
detected by zymography was due to proteases other than MMP-9/MMP-2. To exclude 
this possibility and to confirm the presence of MMP-2 in conditioned medium, samples 
were analyzed by immunoblotting with anti-MMP-2 antibody. MMP-9 was not further 
evaluated by this methodology. Interestingly, the MMP-2 specific signals were only 
detected in nonconcentrated conditioned medium from cell lines that secreted high levels 
o f MMP-2 enzymatic activity; however, when CM was concentrated 10-fold, the results
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o f western blot analysis for MMP-2 protein correlated with results obtained by 
zymography. Western blot analysis confirmed that HNSCC cell lines secreted MMP-2. 
In addition, treatment o f CM with 50 mM EDTA abolished gelatinase activity, further 
confirmation that the gelatinase activity detected in zymography was divalent cation- 
dependent MMP-9/MMP-2. Taken together, the results demonstrated that western blot 
analysis o f  MMP-2 protein was less sensitive than enzymatic detection o f MMP-2 by 
zymography. Ir. addition to detection o f MMP-2 in conditioned medium, we also 
analyzed the expression o f MMP-2 protein in cell lysates by western blot analysis. MMP- 
2 expression in cell lysates was correlated with MMP-2 secretion in most cell lines except 
FaDu and A 431. FaDu cells exhibited a high level o f  MMP-2 in cell lysates, which was 
barely detectable in CM. In contrast, A431 cells produced minimum MMP-2 in cell 
lysates, yet exhibited high levels o f MMP-2 activity in CM. Different levels o f MMPs in 
cell lysates and conditioned medium from specific cell lines may reflect differences in the 
efficiency o f intracellular transport and secretion o f MMPs into the culture medium.
There is ample evidence that the basement membrane is compromised in invasive 
HNSCC. Using immunohistochemistry, a depletion o f  type IV collagen and Iaminin in 
the basement membrane has been linked to lymph node metastasis (141,142). In the 
present study, we demonstrated that constitutive secretion o f  MMP-2 was correlated with 
invasive potential in 5 o f 6 HNSCC cell lines tested. The results were consistent with a 
previous report which showed the association o f MMP-2 expression with invasive 
behavior o f  oral carcinoma in a limited number o f cell lines (77). In support o f  these 
findings, MMP-2 expression has been detected in vivo in small nests o f cells at the
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advancing tumor front o f oral carcinoma and the presence of MMP-2 was related to 
lymph node metastasis (143). However, several studies have demonstrated that MMP-2 
present in carcinoma in vivo may derive from the tumor stroma rather than tumor cells. 
MMP-2 immunoreactivity was found in the peripheral cell layer o f neoplastic islands but 
MMP-2 mRNA expression was confined to fibroblasts (144,145) suggesting that tumor 
cells may be capable o f  utilizing MMPs produced by stromal cells to facilitate invasion. 
Although a role for stromal cells in the production o f MMPs in vivo cannot be ignored, 
the detection and identification o f authentic MMP-2 in epithelial HNSCC cell lines 
argues strongly for MMP production by the tumor cell.
Degradation o f ECM is a highly controlled process and depends on the balance o f 
MMPs and TIMPs. Up-regulation o f MMPs or down-regulation o f TIMPs tilts the 
balance towards proteolytic degradation o f the ECM and promotes tumor invasion (13). 
We have demonstrated that MMP-2 overexpression was associated with tumor cells o f 
high invasive potential. Because TIMP-2 preferentially binds to and inhibits MMP-2. we 
assessed TIMP-2 expression and secretion by HNSCC cell lines by western blot analysis 
and reverse zymography. HNSCC cell lines exhibited different levels o f TIMP-2 activity 
in CM as measured by reverse zymography which correlated with TIMP-2 protein levels 
in CM detected by immunoblotting. Unlike MMP-2 secretion, we found no association 
between TIMP-2 secretion and Matrigel invasion. TIMP-2 levels were not consistently 
decreased in highly invasive HNSCC cells (EVSCC14M and EVSCC17M) nor increased 
in weakly invasive lines (eg., EVSCC19M and UMSCC10A). Thus, our results support 
the concept that up-regulation o f MMP-2 rather than down-regulation o f TIMP-2
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determines the invasive phenotype o f  HNSCC cells. Similar findings were reported in 
giant cell tumors o f bone (69). In contrast, reduced TIMP levels were associated with 
prostate tumor cells (70). Collectively, the data emphasize an imbalance o f secretion 
between MMPs and TIMPs. which may be tumor-type dependent.
Cell attachment to extracellular matrix proteins represents the initial and crucial 
step in the invasion process o f tumor cells (13). To further characterize the invasive 
phenotype o f HNSCC cells, we assessed the ability o f HNSCC cells to adhere to ECM 
proteins by an in vitro adhesion assay. HNSCC cell lines exhibited differential adhesion 
to the ECM proteins fibronectin, laminin, and type IV collagen. Cell adhesion to ECM 
proteins was dose dependent, suggesting that binding o f HNSCC cells to ECM proteins 
was specific. Cell adhesion was correlated with Matrigel invasion in 4 o f 6 cell lines 
tested. Highly invasive cell lines. EVSCC14M and EVSCC 17M. were highly adhesive 
whereas weakly invasive ceil lines. EVSCC 18 and FaDu, were less adhesive. In contrast, 
weakly invasive EVSCC 19M and UMSCC 10A cells exhibited elevated levels of 
adhesion to most ECM proteins, suggesting that cell adhesion to ECM proteins is 
necessary but not sufficient for Matrigel invasion. Interestingly, we observed that 
HNSCC cells were either adherent to all or none o f the ECM proteins evaluated. This 
generalized adhesive property to ECM proteins found with HNSCC cells has also been 
observed in other tumor cell types (25,146, 147). Although the mechanism(s) underlying 
this all or none cell adhesive response to ECM proteins is currently unknown, one 
possibility is that integrin receptors for ECM proteins may be upregulated in a subset o f  
HNSCC. Enhanced expression o f integrin receptors on tumor cells would be expected to
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increase cell adhesion to ECM proteins and facilitate tumor cell migration and invasion. 
In support o f this hypothesis, a recent study demonstrated that over-expression o f integrin 
subunits a2. a3, a5 , a 6  was correlated with tumor invasion and metastasis o f  squamous 
cell carcinoma o f the oral cavity (148). Since a  subunits o f integrin are able to associated 
randomly with (3 subunits in vivo, overexpressed a  subunits resulted in the up-regulated 
expression of a number o f integrin receptors for ECM proteins, including fibronectin, 
laminin, and type IV collagen tested in the present study (148). An alternative 
explanation to account for the generalized increase in cell adhesion to ECM proteins by 
specific tumor cells is based on the state o f integrin activation. Integrins exist in either 
high or low affinity states with respect to their extracellular ligands. We speculate that 
integrins are constitutively activated in specific HNSCC tumor cell lines thus enabling 
the high affinity binding to a number o f different ECM proteins. The mechanistic basis 
of integrin activation is poorly understood. However, the activating process appears to be 
regulated by Ras-related GTPases and their downstream effectors (149). In support of 
this concept, a recent study has shown that the activated a llbp3  integrin enhanced cell 
adhesion and invasion o f human melanoma cells (150). Clearly, further studies are 
required to distinguish among the above possibilities.
Integrin mediated cell adhesion to the ECM is a complex process that occurs in 
specialized structures termed focal contacts or focal adhesions. At these adhesions, 
integrins bind externally to ECM proteins and internally to cytoskeletal proteins. Studies 
have shown that integrins can interact with same ECM protein and that an individual 
integrin can recognize and bind to different ECM protein ligands (20). Another layer of
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complexity for integrin mediated cell-ECM interaction is the involvement o f integrins in 
the activation o f  signal transduction pathways. By interacting with ECM protein ligands, 
integrins can sense molecular cues in the extracellular environment and transduce these 
signals across the cell membrane into the nucleus via a variety o f signal transduction 
pathways to modulate cell behavior. In addition, one integrin can regulate the biological 
function o f another integrin family member, a process referred to as integrin cross-talk, 
the mechanistic basis o f  which is unknown (20). Regardless o f the above complexities, 
the central theme o f integrin-ECM interactions is the recognition o f short peptide 
sequences within the large ECM protein. One well-characterized integrin recognition 
sequence is arginine-glycine-aspartic acid (RGD). Studies with other tumor cell types 
showed that many integrin regulated biological events were RGD dependent e.g. cell 
adhesion, spreading, migration and invasion (21). Likewise, we demonstrated that the 
RGD peptide inhibited HNSCC cell adhesion to fibronectin and laminin in a dose- 
dependent manner, suggesting that cell adhesion to fibronectin and laminin was RGD 
dependent. RGD peptide did not inhibit HNSCC cell adhesion to type IV collagen, 
indicating that integrin binding to type IV collagen was mediated by sequences other than 
RGD. In contrast to RGD, the control peptide, RGE, had no effect on cell adhesion to any 
of the ECM proteins. Thus, this single amino acid change completely abolished RGD 
anti-adhesive activity. The results demonstrated that inhibition o f cell adhesion to 
fibronectin and laminin by RGD peptide was specific. In addition, we also compared the 
efficiency o f the RGD tripeptide with the peptide GRGDSP to block cell adhesion to 
fibronectin. GRGDSP peptides were two-fold more efficient than RGD tripeptides, 
suggesting that amino acids adjacent to RGD increase the efficiency o f integrin-RGD
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interactions. Overall, our results are consistent with previous reports (30) and 
demonstrate that cell adhesion to ECM proteins plays an important role in the invasive 
process o f HNSCC cells.
In past decades, increasing interest has focused on deciphering the molecular 
mechanisms underlying tumor invasion. It was proposed that tumor cell invasion consists 
o f  three sequential steps: cell adhesion, proteolytic degradation o f ECM proteins, and 
chemoattractant directed migration. The proposed three-step hypothesis received 
extensive experimental support and has elucidated molecular events related to each step 
o f  tumor invasion and subsequent metastasis formation (13). However, the step-wise 
process o f invasion has not been tested systematically in the context o f HNSCCs. In the 
present study, we first characterized the invasive phenotype o f six HNSCC cell lines by 
measuring tumor cell invasion through a reconstituted basement membrane, cell adhesion 
to ECM proteins, MMP-2/MMP-9 production and cell migration. The results 
demonstrated that high invasive HNSCC cell lines exhibited enhanced adhesion to ECM 
proteins. MMP-2 production, and directed cell migration toward chemoattractants. 
Defects in one or more of these properties render the cell less or non-invasive. Our 
results demonstrate that the three-step model o f tumor invasion can be expanded to 
include HNSCCs.
4.2 MMP-2 production is necessary for Matrigel invasion
The role o f MMPs in tumor invasion has been clearly established (151). MMP-2,
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which cleaves basement membrane collagen, was the first member o f the 
collagenase family to be closely linked with the invasive phenotype (152). Expression of 
MMP-2 has been associated with tumor invasion and metastasis in many types o f 
malignancy (38). However, the role o f MMP-2 in tumor cell invasion by HNSCCs was 
not clearly established. We have demonstrated that over-expression o f MMP-2 rather 
than down-regulation o f TIMP-2 tilted the balance towards ECM degradation and that 
overexpression of MMP-2 was associated with the in vitro invasive potential o f HNSCC 
cell lines. Other studies showed that expression o f MMP-2 was correlated with lymph 
node metastasis in oral squamous cell carcinoma (77). To provide more direct evidence 
that MMP-2 production was necessary for, and not simply correlated with, the invasive 
potential of head and neck tumors cells, we demonstrated that antibody to MMP-2 
blocked in vitro invasion of HNSCC cell lines. However, inhibition of in vitro invasion 
by anti-MMP-2 was inefficient. Large doses o f MMP-2 antibody (100 ug/ml) were 
required to achieve substantial inhibition, suggesting that even high concentrations of 
antibody were insufficient to neutralize excess MMP-2 secreted by the cell line. 
Alternatively, HNSCC cells may secrete other proteases involved in Matrigel invasion. 
In support o f our findings. Albini et al (74) showed that MMP-2 specific antibody 
inhibited HT1080 tumor cell invasion to the same extent as TIMP-2. In addition, MMP-2 
antibody inhibited HT1080 cell migration by 27% suggesting that the effect o f  MMP-2 
antibody on HT1080 cell invasion was partially mediated by blocking cell migration. 
Inhibition of cell migration by MMP-2 antibody supports recent evidence that MMPs are 
not solely involved in the proteolytic digestion o f the ECM, but can also modify cell 
attachment. Thus, MMP-2 antibody may inhibit cell migration by interfering with cell
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attachment and detachment mediated by membrane-MMP-2 (74). The role o f  MMP-2 in 
cell migration by HNSCC remains to be determined.
4.3 MMP production and cell migration is regulated bv integrin mediated cell-ECM 
interaction
Cell adhesion to ECM proteins is the initial step in tumor invasion. It represents 
the most direct cell-ECM interaction. Accumulating evidence has demonstrated the 
importance o f ECM and the tissue microenvironment in tumor progression and metastasis 
(153). Utilizing the nude mouse model, we have shown previously that the site o f tumor 
implantation, i.e., the tissue microenvironment, strongly affects tumor cell behavior and 
invasion by HNSCCs (132). In work described above, we demonstrated that cell 
adhesion to ECM proteins is correlated with tumor invasion by HNSCC cells in vitro. In 
this section, we discuss the evidence that cell-ECM interactions regulate MMP 
production and cell migration in the context o f  our understanding o f how these 
interactions may regulate the invasive behavior o f  HNSCC.
a. Regulation o f  MMP production by cell-ECM interactions
MMPs are secreted as soluble, latent proenzymes that are activated by proteolytic 
cleavage o f an amino-terminal domain. Thus, a clearer understanding o f MMP activation 
is critical to defining the invasive tumor phenotype. In the previous section, we discussed 
evidence showing that the extent o f proMMP-2 secretion was correlated with Matrigel
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invasion in 5 o f 6 HNSCC cell lines. One exception, EVSCC 18 cells, produced large 
amounts o f proMMP-2 but the cells were poorly invasive suggesting that proMMP-2 
secretion may be necessary but not sufficient for acquisition o f the invasive phenotype. 
Previous studies have shown that only activated MMPs are able to digest the ECM (13). 
Consistent with these findings, activated MMP-2 was linked to lymph node metastasis o f  
oral carcinoma cells (154,155). However, in our study, non-stimulated HNSCC cells 
produced barely detectable activated forms o f MMP-2 assessed by gelatin zymography. 
To be functional, proMMP-2 must somehow be activated during the process o f Matrigel 
invasion. Because cell-ECM interactions were demonstrated previously to stimulate 
MMP expression (22), we reasoned that ECM proteins might stimulate MMP-2 secretion 
or activation by HNSCC cells. The experiments to test this hypothesis generated some 
unexpected results (see Fig. 3-13 & 3-14). First, MMP-2 secretion and/or activation was 
unaffected by fibronectin or laminin in three representative highly or weakly invasive 
HNSCC cell lines. Second, and unexpectedly, fibronectin stimulated secretion and 
activation o f proMMP-9 in dose-dependent manner by each cell line. Laminin also 
stimulated MMP-9 production, but less potently and in only one o f the cell lines 
suggesting that the effect o f  laminin on MMP-9 secretion was cell line-specific. Cell 
specific regulation o f  MMP-9 by laminin is likely to reflect laminin receptor 
heterogeneity in HNSCCs. We also observed that type IV collagen at low doses had no 
effect on MMP-9/MMP-2 secretion, whereas higher doses (>40 ug/ml) inhibited 
secretion o f MMP-9/MMP-2. A similar example o f suppression of MMP secretion by 
fibronectin and the a 4 p i  integrin was reported in fibroblasts (156). Although the impact 
o f negative signaling by ECM-integrins is poorly understood, it seems likely that integrin
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receptors and ECM ligands collaborate in vivo to regulate MMP expression in the context 
of the tissue microenvironment. Because both MMP-2 and MMP-9 are known to digest 
basement membrane constituents, we speculate that constitutive secretion o f MMP-2 may 
be responsible for the initial breakdown o f the basement membrane in vivo and that 
subsequent up-regulation and activation o f MMP-9 by cell-ECM interactions may 
potentiate ECM degradation and tumor invasion.
Consistent with our findings, recent studies have shown that integrin-mediated 
cell-ECM interactions influence MMP expression and/or activation. Type I collagen up- 
regulated MMP-1 secretion in skin keratinocytes (157) and human osteosarcoma cells 
(35). Similarly, fibronectin was shown to induce MMP-9 secretion in a variety o f cell 
types including fibroblasts (158), macrophages (159), and ovarian carcinoma cell lines 
(34). In addition, other studies have shown that type I collagen induced MMP-2 
activation in normal and malignant human fibroblastoid ceils (160), and laminin was 
reported to stimulate MMP-2 activation in rhabdomyosarcoma cells (161).
Evidence from several laboratories has demonstrated that regulation o f MMPs by 
ECM proteins is dependent on the expression o f integrin receptors. For example, cross- 
linking o f integrins with antibodies against p i and a3 integrins stimulated MMP-9 
production in oral keratinocytes (162) and anti-a3 integrin resulted in MMP-2 activation 
in rhabdomyosarcoma cells (161). Similarly, clustering o f the integrin ocv(}3 with anti- 
integrin antibody led to increased expression o f MMP-2 in melanoma cells (36). In 
addition, upregulation o f P3 integrin was associated with MMP-9 expression in
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melanoma cell tumors transplanted into nude mice (163). Although characterization of 
the integrin receptors in HNSCC cell lines is beyond the scope o f  this work, it seems 
reasonable to conclude that specific integrin engagement with ECM proteins induces 
MMP-9 expression in head and neck tumor cells. Further studies are needed to uncover 
the mechanisms responsible for fibronectin-induced activation of MMP-9.
b. Cell-ECM interactions regulate cell motility o f  HNSCCs
Cell-ECM interactions not only regulate MMP secretion but also modulate cell 
migration. Accumulating evidence has demonstrated that ECM proteins are able to 
stimulate locomotion in many types o f  tumor cells including melanoma, glioma, 
mesothelioma, fibrosarcoma, osteosarcoma, lung and breast carcinoma ( reviewed in 49). 
The motility-stimulating ECM proteins include vitronectin, fibronectin. laminin, type I 
collagen, type IV collagen and thrombospondin (49). In the previous section, we 
discussed evidence showing that cell motility is an important determinant o f the invasive 
phenotype of HNSCCs. However, little is known about the effect o f  ECM proteins on cell 
migration by HNSCC cells. In experiments aimed to determine the effect o f ECM 
proteins on tumor cell migration (chemotaxis), we demonstrated that fibronectin, laminin, 
or type IV collagen stimulated chemotaxis o f two highly invasive HNSCC cell lines over 
a broad dose range, whereas these ECM proteins failed to stimulate chemotaxis of a 
weakly invasive HNSCC cell line (see Figs. 3-16 to 3-18). Two observations emerged 
from the results o f these experiments. One, the highly invasive cell lines exhibited high 
motility in the absence of exogenous stimulation by ECM proteins (so called
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chemokinesis). In the present study, we demonstrated high motility in highly invasive cell 
lines even without stimulation. The mechanism underlying the enhanced motility is not 
clear. Interestingly, we have found that one o f the highly invasive cell lines 
(EVSCC 17M) has high levels o f  EGF receptor expression by immunohistochemistry 
(unpublished observations). Since EGF has been shown previously to stimulate cell 
migration by a variety o f tumor cell types, we speculate that the high endogenous motility 
seen in EVSCC 17M might be due to activation o f the EGFR signaling pathway. Indeed, 
we have found that EGF receptor blocking antibody A225 inhibited cell migration dose- 
dependently (unpublished observations) suggesting the presence o f an EGF-EGFR 
autocrine loop in EVSCC 17M cells resulting in high endogenous motility. Second, cell 
migration in response to fibronectin and type IV collagen was biphasic. Low and 
intermediate doses stimulated whereas high doses reduced cell migration. The same 
phenomenon has been observed in other tumor cell types without clear explanations (25). 
One possibility is that high doses o f ECM proteins result in integrin internalization (164). 
Temporary down regulation o f the integrin receptor may lead to reduced motility. Other 
studies have shown that tumor cells have the ability to assemble fibronectin and the 
assembled fibronectin polymer could inhibit cell migration (165). High doses o f 
fibronectin may facilitate fibronectin assembly, thus inhibiting cell migration. Although 
our results are unable to explain these observations, the findings demonstrate that cell- 
ECM protein interactions regulate chemotaxis by HNSCC cells.
We have shown that cell contacts with ECM proteins can modulate MMP 
secretion and cell motility. These cell-ECM interactions are mediated by integrin
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receptors. Ligand binding and activation o f integrins is dependent on a peptide 
recognition m otif (RGD) recognized by several members o f the integrin family (20). To 
provide evidence that cell contact with fibronectin was integrin receptor dependent, we 
demonstrated that synthetic RGD peptides specifically inhibited cell migration in 
response to fibronectin. Previous studies have shown that RGD peptides can block cell 
migration by specific ECM proteins in a variety o f tumor cells (166). Thus, our findings 
support and extend earlier work and demonstrate that fibronectin-stimulated HNSCC 
locomotion is RGD dependent and at least partially mediated by integrins. Which integrin 
receptors are involved in regulation o f HNSCC cell motility by ECM proteins is currently 
unknown. Studies in the past have linked a6p4 and avp6 to local invasion and metastasis 
o f  HNSCCs (167. 168). Recent studies demonstrated that expression o f a2. a3 . a5 . and 
a 6  integrin subunits was correlated with tumor invasion and poor prognosis o f  HNSCCs 
(148). Collectively, the findings suggest that these integrins may be good candidates for 
motility receptors. Further investigation is needed to identify and characterize integrin 
receptors critical for HNSCC cell migration and their role in tumor cell invasion. In the 
future, it may be possible to develop and clinically evaluate short peptide sequences (eg.. 
RGD-like) capable o f blocking tumor cell invasion.
4.4 Involvement o f calcium signaling in regulation o f the invasive phenotype o f HNSCCs
Intracellular calcium homeostasis is a common regulatory point in many signal 
transduction pathways and is known to be essential for several biological process 
including cell proliferation, angiogenesis. cell migration and invasion (88). To determine
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if calcium-signaling was important in HNSCC biology, we made use o f  CAI. a novel 
inhibitor o f calcium influx. CAI has been shown to inhibit cell adhesion, proliferation, 
and cell migration in many cell types (126).
We demonstrated that CAI inhibited the invasiveness and motility o f  HNSCC cell 
lines in vitro, consistent with previous reports showing that CAI is an anti-metastatic 
agent (126.169). We also demonstrated that CAI inhibited both MMP-2 and MMP-9 
production by HNSCC cells, indicating that calcium homeostasis is important in 
regulation o f MMP secretion. This supports and extends previous studies showing that 
CAI inhibits MMP-2 production by fibrosarcoma and endothelial cell lines (170.171). 
Whether CAI inhibits the production o f MMPs at level o f  transcription or 
translation/secretion in HNSCC is not clear. In a recent study. CAI was found to reduce 
MMP-2 mRNA transcription (170). Further work is necessary to determine if  CAI also 
inhibits transcription o f MMPs in HNSCCs. The reduction o f MMP activity by CAI 
suggests that inhibition o f  the invasive potential o f HNSCCs also involves inhibition of 
MMP production.
We demonstrated that integrin mediated cell-ECM is important in regulating cell 
migration and MMP production. Studies by others demonstrated that integrin receptor- 
ligand binding and activation leads to an influx o f intracellular calcium. Our results 
demonstrated that blocking calcium influx with CAI inhibited cell migration, MMP 
production, and Matrigel invasion. Thus, our findings suggest that regulation o f cell 
migration and MMP production by cell-ECM interactions is dependent on calcium
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signaling and indicate that interruption o f  calcium-dependent signaling pathways may 
represent a useful strategy for the therapeutic management o f HNSCC.
4.5 FAK expression and activation is important in regulation o f the invasive phenotype o f
HNSCCs
A substantial body o f evidence has demonstrated a critical role for FAK in 
integrin-mediated signaling (94, 96). Moreover, increased FAK expression has been 
proposed as a biomarker for invasive and metastatic tumors (105). Because the role o f 
FAK in integrin-mediated signaling in HNSCC cells and the biological consequences o f 
FAK expression and tyrosine phosphorylation have not been fully explored, we analyzed 
FAK expression and phosphorylation in HNSCC cell lines. The results demonstrated that 
HNSCC cell lines exhibited differential levels o f FAK protein and phosphorylated FAK. 
FAK phosphorylation was correlated with cell migration and Matrigel invasion o f 
HNSCCs, suggesting that FAK activation contributes to the invasive phenotype o f 
HNSCCs.
To investigate whether FAK signaling has a causal role in the invasive phenotype 
o f HNSCC, we overexpressed FAK in a weakly invasive HNSCC cell line, EVSCC 18. 
The results demonstrated that forced expression o f FAK significantly stimulated MMP-9 
production, cell migration towards chemoattractants (NIH3T3 conditioned medium or 
fibronectin), and Matrigel invasion. Consistent with these results, overexpression o f
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FAK in Chinese hamster ovary (CHO) cells stimulated migration towards fibronectin 
(110). Thus, our results confirmed and extended earlier work and suggested that FAK 
contributes in some way to the acquistion o f  the invasive phenotype o f HNSCCs.
Although forced FAK expression significantly increased the in vitro invasive 
potential o f  weakly invasive EVSCC 18 cells, they never achieved the invasive potential 
o f  highly invasive cell lines, EVSCC 14M and EVSCC 17M. Thus, we conclude that FAK 
overexpression is not sufficient for acquistion o f  the invasive phenotype and that other 
factors are needed for development o f the invasive and metastatic phenotype. We 
speculate that sub-cellular localization o f FAK and FAK-associated proteins to focal 
contact sites are important determinants in promoting enhanced rates o f cell migration. 
Further experiments are needed to address this possibility.
To further investigate the role o f  FAK in the invasive phenotype, we sought to 
inhibit FAK function in highly invasive cells by overexpression o f FRNK, an 
alternatively spliced product o f  the FAK gene, which is proposed to act as an in vivo 
competitive inhibitor o f FAK (104). Specifically, FRNK was transfected into highly 
invasive EVSCC 14M cells, which expressed high levels o f FAK and phosphorylated 
FAK. Subsequent analysis demonstrated that forced expression of FRNK in EVSCC 14M 
cells slightly inhibited FAK expression, but significantly decreased FAK 
phosphorylation. Previous studies have shown that mouse fibroblasts derived from 
FAK -/- knockout mice exhibited decreased rates o f cell migration in vitro relative to 
cells from wild type mice (109) and that this migration defect could be rescued by
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transient FAK overexpression in FAK -/- cells (172). Moreover, transient overexpression 
o f FRNK in Balb/3T3 fibroblasts and human endothelial cells reduced cell migration 
(173) and stable overexpression o f FRNK blocked migration of LNCaP prostate tumor 
cells (174). Therefore, the augmented invasive potential o f  EVSCC 14M-FRNK 
transfectants. manifested as increased migration. Matrigel invasion, and MMP-9 
secretion, was unexpected and not in agreement with the above findings. In support o f 
our findings, enhanced FAK phosphorylation was associated with decreased migration in 
NIH3T3 fibroblasts and bovine endothelial cells and down modulation o f FAK 
phosphorylation by expression o f a v-src kinase-negative mutant increased cell migration 
(175). Taken together with our findings, the data suggest that FAK activation is tightly 
regulated and that increases or decreases in FAK phosphorylation modulate cell function. 
Alternatively, our results support a model o f  a dual integrin-mediated signaling pathway 
in HNSCC cells that was reported previously in fibroblasts (176). In this model, both 
FAK-dependent and FAK-independent mechanisms for integrin-mediated MAPK 
activation and downstream signaling can occur. Our findings of significantly decreased 
FAK phosphorylation in FRNK overexpressors suggest that integrin-mediated 
downstream cellular functions can occur independent o f FAK function.
Finally, our results are compatible with a model in which FRNK overexpression 
could trigger downstream events leading to altered gene expression such as cell 
migration. Matrigel invasion, and MMP-9 secretion, as observed in EVSCC 14M-FRNK 
transfectants. FRNK lacks catalytic activity but contains three proline-rich domains 
which interact with SH3 domains in target proteins, a tyrosine phosphorylation site
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(Tvr925). and a focal adhesion-targeting (FAT) domain responsible for targeting the 
protein to focal adhesions (91.177). We propose a model in which FRNK is 
phosphorylated on Tyr925 by endogenous EVSCC 14M FAK; this leads to the 
recruitment o f Grb-2 and SOS to Tyr925 via their SH2 domains and the formation of 
signaling complexes which would be targeted to focal adhesions by FAT sequences in 
FRNK and promote activation o f the Ras signal transduction pathway and downstream 
cellular functions. Support for this model derives from previous studies showing that 
overexpression o f a kinase-defective FAK in CHO cells stimulated migration on 
fibronectin (110). Although the underlying mechanisms by which FRNK overexpression 
leads to augmentation o f  the invasive phenotype of HNSCC cells remain to be 
investigated, our results demonstrate that the FAK signaling pathway has a critical role in 
the modulation of cellular determinants o f the invasive tumor cell phenotype.
In summary , evidence discussed in this section support the notion that FAK- 
dependent signaling plays an important role in generating the invasive phenotype of 
HNSCCs. Further investigation is required to dissect the signal transduction pathways 
downstream o f FAK to clarify how FAK activation affects tumor cell invasion and 
metastasis.




Local invasion and lymph node metastasis are predictive o f  a poor clinical outcome 
and the major obstacle to cure o f  HNSCCs. A greater understanding o f the cellular and 
molecular mechanism(s) underlying the invasive phenotype o f HNSCCs is expected to 
translate into new therapeutic strategies. Utilizing a panel o f  HNSCC cell lines previously 
established in our laboratory, we sought to identify and characterize the cellular and 
molecular determinants involved in the invasive process o f  HNSCCs.
The invasive phenotype o f six HNSCC cell lines was analyzed by measuring tumor 
cell invasion though a reconstituted basement membrane (Matrigel). cell adhesion to 
ECM proteins. MMP-2/MMP-9 production and cell migration. The results demonstrated 
that highly invasive HNSCC cell lines exhibited enhanced adhesion to ECM proteins, 
increased MMP-2 production, and directed cell migration toward chemoattractants. 
Defects in one or more o f these properties rendered tumor cells less or non-invasive. Our 
results with HNSCC cells support a model o f  tumor invasion that involves tumor cell 
adhesion, ECM proteolysis, and cell migration.
In the process o f  characterizing the invasive phenotype o f HNSCC cell lines, we 
found that MMP-2 production was associated with Matrigel invasion. To provide more 
direct evidence that MMP-2 production was necessary for, and not simply correlated 
with, the invasive potential o f HNSCCs, we demonstrated that antibody to MMP-2
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blocked in vitro invasion of the highiy invasive HNSCC cell line. EVSCC 14M, in a dose 
dependent manner, confirming that MMP-2 was a necessary determinant o f invasive 
potential.
Cell adhesion to ECM proteins is the initial step in tumor invasion and has 
previously been shown in other tumor types to be important in the regulation of other 
steps o f the invasive process. We postulated that cell-ECM interactions might also be 
important in modulating the invasive phenotype o f HNSCCs. To test this hypothesis. 
HNSCC cells were exposed to soluble ECM proteins and measured for changes in cell 
migration. MMP production and/or activation. ECM proteins (fibronectin. laminin. or 
collagen type IV) stimulated cell migration o f highly invasive cell lines but failed to 
stimulate migration o f a weakly invasive cell line. Fibronectin-stimulated cell migration 
was specifically blocked by RGD peptides, a known recognition m otif for integrin- 
fibronectin binding. Fibronectin also stimulated MMP-9 secretion and activation in a 
dose-dependent manner by HNSCC cell lines but had minimal to no effect on MMP-2 
secretion and/or activation. Laminin weakly and selectively stimulated MMP-9 secretion 
but was without effect on MMP-2 secretion and/or activation. Collectively, our results 
suggest that cell migration and MMP-9 production by HNSCC cells were regulated by 
integrin-mediated cell-ECM interactions.
Integrin-mediated cell-ECM interactions are not only important in regulation o f a 
variety o f biological process but are also responsible for the generation and transmission 
o f signals across the cell membrane. Previous studies demonstrated that intracellular
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calcium was an important component o f  the integrin-mediated signal transduction 
pathways. Therefore, we sought to determine the role o f calcium signaling in the 
regulation o f MMP secretion and generation o f the invasive phenotype o f HNSCCs. 
Utilizing a novel calcium influx inhibitor, carboxyamido-triazole (CAI). we demonstrated 
that inhibition o f calcium influx blocked cell motility, MMP-9/MMP-2 secretion, and 
Matrigel invasion. Our findings suggest that calcium signaling plays an important role in 
modulating the invasive phenotype o f HNSCCs.
FAK has been implicated in integrin-mediated signaling pathways and linked 
previously to cell spreading, migration and invasion. To explore the role o f  FAK in 
integrin-mediated signaling in HNSCC cells and the biological consequences o f FAK 
expression and activation, we analyzed FAK expression and phosphorylation in HNSCC 
cell lines. The results demonstrated that FAK phosphorylation was correlated with cell 
migration and Matrigel invasion of HNSCCs, suggesting that FAK activation contributes 
to the invasive phenotype o f HNSCCs. To investigate whether FAK signaling has a 
causal role in the invasive phenotype o f  HNSCC, sense FAK or its negative regulator, 
FAK-related non-kinase (FRNK), was expressed by stable transfection of HNSCC cell 
lines to assess the consequences o f FAK or FRNK transfection on the invasive 
phenotype. Overexpression o f FAK in weakly invasive EVSCC 18 cells significantly 
increased Matrigel invasion, MMP-9 production, and cell migration. Overexpression of 
FRNK in highly invasive EVSCC 14M cells reduced FAK phosphorylation and 
expression, but unexpectedly, enhanced Matrigel invasion, MMP-9 secretion, and cell 
migration. Taken together, our findings suggest that the FAK signaling pathway has a
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critical role in the modulation o f  cellular determinants o f  the invasive tumor cell
phenotype.
In conclusion, data presented in the present study demonstrated that tumor cell 
invasion in HNSCC is a complex process involving three repeated sequential steps: 
adhesion, proteolytic degradation o f  the basement membrane, and cell migration. These 
three steps are linked and interdependent. For example, cell adhesion to ECM triggers a 
series o f signal transduction pathways that involve calcium mobilization, focal adhesion 
kinase activation and downstream events leading to alteration of cell function manifested 
by migration and MMP production. Our working model extends the previous three step 
hypothesis o f  tumor invasion by underscoreing FAK as an integrator o f  multiple 
signaling pathways. Efforts to determine the role o f  FAK in the integration and 
propagation o f signal transduction pathways should lead to a better understanding o f the 
molecular mechanisms for generating the invasive phenotype o f HNSCCs, which may in 
turn, lead to the discovery o f new targets for therapy o f invasive HNSCC. Identification 
o f cellular and molecular determinants o f  HNSCC may prove useful potentially as 
biomarkers o f tumor cell behavior, prognosis, and for guiding treatment strategies.
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